**THURSDAY, JUNE 5**TimePresenting AuthorResearch Report Title**NEUROLOGY**4:25 PMAnnie Chen‐AllenEvaluation of Lactate Dehydrogenase and Creatine Kinase in Cerebrospinal Fluid of Dogs with Neurological Diseases4:50 PMPaula Martin‐VaqueroAnalysis of Cytokine Concentrations in the Cerebrospinal Fluid of Great Danes with and without clinical Signs of Cervical Spondylomyelopathy5:25 PMStephanie ThomovskyAccuracy of Preoperative Computed Tomography and Magnetic Resonance Imaging as Compared to Surgical Findings in Chondrodystrophic Dogs with Intervertebral Disc Disease5:50 PMHeidi Barnes HellerSerum Phenobarbital Levels in Cats Following Chronic Transdermal AdministrationONCOLOGY11:30 AMJenna BurtonEvaluation of Client Perceptions Regarding Barriers and Benefits to Veterinary Oncology Clinical Trials Participation**FOOD ANIMAL**4:25 PMSanjay KapilEpidemiology of Bovine Lymphotropic Herpes Virus4:50 PMMireille MeylanTransist Time in the Large Intestine of Cows with Cecal Dilation/Dislocation in Comparison with Healthy Control Cows with Left Displacement of the Abomasum5:25 PMPaul WalzThe Effects of Modified Live Vaccines on Reproductive Performance5:50 PMStacey ByersEvaluation of Glucose Response to Three Insulin Types and a Continuous Glucose Monitoring System in Healthy and Sick Alpacas

**FRIDAY, JUNE 6**TimePresenting AuthorResearch Report Title**CARDIOLOGY**2:10 PMLisbeth OlsenSerotonin Concentration is Elevated in Platelet Rich Plasma and Left Ventricular Myocardial and Mitral Valve Leaflet Tissue in Dogs with Myxomatous Mitral Valve Disease2:35 PMRosângela CarvalhoNovel Vasodilator Prototype Drug (LASSBio 897) and Its Action on the Cardiovascular System of Dogs3:10 PMSonja FonfaraThe Influence of Age and Systemic Diseases on Cardiac Inflammation and Remodeling in Cats3:35 PMSophy JestyMechanisms for Sudden Cardiac Death in Endurance Athletes: Support for Exercise‐Induced Arrhythmogenesis4:25 PMVirginia Luis FuentesA Cross‐Sectional Study of Cardiomyopathy Prevalence in 780 Cats in Rehoming Centers (The CatScan Study)4:50 PMDan OhadDoes Pimobendan Therapy for Canine Secondary Pulmonary Arterial Hypertension Alter Trans‐Semilunar Valve Spectral Doppler Variables?5:25 PMChristophe AmbergerHypertrophic Cardiomyopathy in the Sphynx Cat: Genetic Aspects, Clinical Evolution, Echocardiographic and Morphometry Findings5:50 PMNicole Van IsraelClinicopathologic Features of Dogs and Cats Presented to a Cardiorespiratory Referral Institution Diagnosed with Acute Toxoplasmosis**NEUROLOGY**2:10 PMSimon PlattValidation and Prognostic Value of 2 New Head Trauma Scoring Systems in 84 Dogs2:35 PMRonaldo da CostaDiffusion Tensor Imaging in Dogs with and without Cervical Spondylomyelopathy3:10 PMMario DoleraAtlantoaxial Instability with Incongruence: MRI Findings and Surgical Treatment in 5 Dogs3:35 PMFilippo AdamoCervical Disc Arthroplasty in Dogs with Disc Associated Wobbler Syndrome ‐ Limitations and How to Prevent Possible Complications4:25 PMR. Timothy BentlyA Pilot Study of Levetiracetam Pulse Therapy for Canine Cluster Seizures4:50 PMSofia Cerda‐GonzalezRelationship of Dorsal Atlantoaxial Junction Compressive Lesions (Dural Bands) to Clinical Signs and Syringomyelia in Cavalier King Charles Spaniels5:25 PMPeter DickinsonIdentification of a Glioma Susceptibility Locus in Dogs5:50 PMFiona JamesCanine Awake Ambulatory Wireless Video Electroencephalography**ONCOLOGY**2:10 PMMiguel CamposNew Insights into the Pathogenesis and Treatment of Canine Thyroid Carcinoma2:35 PMLuca MalfassiFrameless Steriotaxis in Small Animal Brain and Spine Radiosurgery3:10 PMRowan MilnerTargeting Gangliosides as Tumors Antigens for Cancer Vaccines3:35 PMChick WeisseRadical Cystectomy and Bilateral Subcutaneous Ureterovesicular Bypass (Sub) Placement for Advanced Urinary Bladder Cancer in Dogs4:25 PMJeffrey BryanRandomized, Blinded, Placebo‐Controlled Trial of Artesunate with Doxorubicin for B Cell Lymphoma of Dogs4:50 PMAmy LeBlancPreliminary Toxicity and Efficacy of the Novel Oncolytic Virus, VSV‐IFNΒ‐NIS, in Tumor‐Bearing Dogs5:25 PMLucas RodriguesThe Enhanced Tumorigenicity of Canine Osteosarcoma Cell Lines is Associated with Enhanced Frizzled‐6 Expression and Side Population Cells5:50 PMLaura GarrettZometa OSA in Dogs**SMALL ANIMAL INTERNAL MEDICINE**8:00 AMKarin AllenspachIL‐1β Protein Expression Is Increased in the Lamina Propria of Dogs with Food‐Responsive Chronic Enteropathies and Correlates with Clinical Activity Index8:25 AMJan SuchodolskiEvaluation of the Fecal Microbiome in Cats with Diarrhea9:00 AMJ Scott WeeseComparison of the Fecal Microbiota of Wild Wolves, Dogs Fed Commercial Dry Diets and Dogs Fed Raw Meat Diets9:25 AMArleigh ReynoldsNutritional Immunomodulation: Spirulina for Immune & Gut Health in Dogs4:25 PMDana ClarkeEvaluation of a Novel Tracheal Stent for the Treatment of Tracheal Collapse in Dogs4:50 PMBrian ScansenTracheal Diameter and Area: Computed Tomography versus Fluoroscopy for Stent Sizing in 12 Dogs with Tracheal Collapse5:25 PMJohn ThomasonEffects of Cyclosporine and Aspirin on Canine Platelet Function5:50 PMM. Katherine TolbertThe Effect of Oral Acid Suppressants on Intragastric pH in Cats**EQUINE**8:00 AMLutz GoehringChoroidal Vasculitis During Experimental and Naturally Occurring EHV‐1 Infections in Horses8:25 AMGillian PerkinsA Novel Strategy to Boost Antibody Production to Equine Herpesvirus Type 1 (EHV‐1) in Foals9:00 AMGabriele LandoltComparison of Innate Immune Responses in Euine Respiratory Epithelial Cells to Modified‐Live Equine Influenza Vaccine and Related Wild‐Type Influenza Virus9:25 AMNigatu AkliluInfectious Diseases of Working Equids: Havemeyer Workshop Report4:25 PMClaudia Cruz VillagranDifferentiation of Equine Mesenchymal Stromal Cells into Neural Cells: Potential for Clinical Applications4:50 PMAllison StewartDisposition of Levetiracetam in Serum and Cerebrospinal Fluid after Single Dose Oral Administration of Pioneer and Generic Levetiracetam in Healthy Adult Horses5:25 PMLara MaxwellFactors Affecting Susceptibility of Young Adult Horses to Equine Herpesvirus Myeloencephalopathy5:50 PML. Nicki WiseGenetic Analysis of a Novel *Theileria Equi* Isolate in the United States**FOOD ANIMAL**4:25 PMMaria PradoDetecting Early Behavioral Markers of Respiratory Disease Development in Young Dairy Calves4:50 PMAmelia WoolumsResponse of Bovine Bronchial Epithelial Cells to Co‐Infection with Bovine Respiratory Syncytial Virus and Mycoplasma Bovis5:25 PMBrent CredillePrevalence of Bacteremia in Dairy Cattle with Acute Puerperal Metritis5:50 PMKeith PoulsenOtitis in Calves

**SATURDAY, JUNE 7**TimePresenting AuthorResearch Report Title**CARDIOLOGY**8:00 AMSonya GordonComplications Associated with Transcatheter PDA Occlusion: Results of an ACVIM Cardiology Survey8:25 AMStacey LeachDilated Cardiomyopathy in Standard Schnauzers with a Homozygous 22 BP Deletion in RBM209:00 AMBrian ScansenComputed Tomography Angiography of the Coronary Arterial Circulation of Bulldogs under Conscious Sedation Is Feasible and Defines Anomalous Anatomy9:25 AMJoshua SternClathrin‐Mediated Endocytosis Impacts Cardiac Outflow Tract Morphogenesis and a Single Codon Insertion in Phosphatidylinositol Binding Clathrin Assembly Protein Is Associated with Newfoundland Dog Subvalvular Aortic Stenosis10:30 AMLisa FreemanInvestigation of Dietary Factors with Possible Associations with Canine Degenerative Mitral Valve Disease10:55 AMLisa FreemanBody Size Is Related to Metabolic Markers and Left Ventricular Hypertrophy in Cats11:30 AMKatja HöglundUsefulness of Plasma Concentration of Chromogranin A as an Indicator of Sympathetic Tone in Dogs with Myxomatous Mitral Valve Disease11:55 AMEtienne CôtéAssessment of Multiple Echocardiographic Parameters in Golden Retriever Dogs with or without Subaortic Stenosis**NEUROLOGY**8:00 AMKaren MunanaPharmacokinetics of Levetiracetam in Epileptic Dogs When Administered Concurrently with Phenobarbital, Bromide, or Phenobarbital and Bromide in Combination8:25 AMDuncan LascellesCharacterisation of Gene Expression in Naturally Occurring Feline Degenerative Joint Disease Associated Pain9:00 AMA. Courtenay FreemanConvection Enhanced Delivery of Cetuximab Conjugated with Iron Oxide Nanoparticles for Canine Intracranial Gliomas: A Pilot Study9:25 AMByeong‐Teck KangSequential Magnetic Resonance Imaging of Experimental Intracerebral Hemorrhage in Dogs10:30 AMArmelle DiquelouCerebellar Abiotrophy in a Litter of Belgian Shepherds10:55 AMJi Hey LimOptimization of a Method for Isolation, Purification and Expansion of Adult Schwann Cells from Dorsal Cutaneous Cervical Nerves in Dogs11:30 AMG. Diane SheltonCongenital Myasthenia Gravis in a Family of Labrador Retrievers Is Caused by a Mutation in the COLQ Gene11:55 AMSilvia SisoDistinct Anatomic Distribution Patterns in Central Nervous System Lymphomas Correlate with Both Magnetic Resonance Imaging Profiles and Unohistological Types**SMALL ANIMAL INTERNAL MEDICINE**8:00 AMJodi WestroppNanoparticles and Calcium Oxalate Stone Formation: New Insights on Calcium Oxalate Pathophysiology8:25 AMEva FurrowMetabolic and Genetic Determinants of Calcium Oxalate Urolithiasis in Dogs9:00 AMJody LulichA Two‐Year‐Long Prospective, Randomized, Double‐Masked Study of Nutrition on the Recurrence of Calcium Oxalate Urolithiasis in Stone Forming Cats9:25 AMJennifer MacLeayComparison of Relative Super Saturation for Calcium Oxalate to a New Method to Determine the Propensity of Urine to Precipitate Calcium Oxalate, the Calcium Oxalate Risk Index10:30 AMMeryl LittmanPrevalence of Variant Alleles Associated with Protein‐Losing Nephropathy in Airedale Terriers10:55 AMJessica QuimbyPlacebo‐Controlled Assessment of Allogeneic Mesenchymal Stem Cells for the Treatment of Feline Chronic Kidney Disease11:30 AMCarrie PalmUrinary Clusterin and Serum Inosine: Biomarkers for Early Identification of Acute Kidney Injury in Dogs11:55 AMB. Duncan X. LascellesEfficacy of Canine Anti‐Nerve Growth Factor Antibody for the Alleviation of Degenerative Joint Disease‐Associated Pain in Dogs**EQUINE**8:00 AMStacey SullivanA Systematic Review and Meta‐Analysis of the Efficacy of Frusemide for Exercise Induced Pulmonary Hemorrhage in Thoroughbred Racehorses8:25 AMNicola PusterlaEmerging Outbreaks of Coronavirus in Adult Horses9:00 AMJeffrey PhillipsSafety and Immunoreactivity of a Xenogeneic DNA Plasmid Vaccine Expressing Human Tyrosinase in Tumor‐Bearing Horses9:25 AMAshley BoyleRetrospective Analysis of *Streptococcus Equi* Subsp *Equi* Infections in 108 Horses in the Field (2005‐2012)10:30 AMKatarzyna DembekAdrenal Steroids, Steroid Precursors nad Neurosteroids in Hospitalized Newborn Foals10:55 AMVeronique LacombeAICAR Administration Affects Glucose Metabolism by Upregulating the Novel Glucose Transporter, GLUT8, in Equine Skeletal Muscle11:30 AMMolly McCueFactors Associated with Variation in the Equine Incretin Response in a Cohort of Morgan Horses and Welsh Ponies11:55 AMBrandy BurgessEpidemiology of *Salmonella enterica* in a Large Animal Veterinary Teaching Hospital

CARDIOLOGY {#jvim12375-sec-0003}
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SEROTONIN CONCENTRATION IS ELEVATED IN PLATELET RICH PLASMA AND LEFT VENTRICULAR MYOCARDIAL AND MITRAL VALVE LEAFLET TISSUE IN DOGS WITH MYXOMATOUS MITRAL VALVE DISEASE {#jvim12375-sec-0004}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**S.E. Cremer^1^, G.E. Singletary^2^, [L.H. Olsen]{.ul}^1^, K. Wallace^3^, J. Häggström^4^, I. Ljungvall^4^, K. Höglund^4^, C.A. Reynolds^2^, N. Pizzinat^5^, M.A. Oyama^2^**

^1^Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark.^2^Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia PA, USA 19104.^3^Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia PA, USA 19104.^4^Department of Clinical Sciences, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, Uppsala, Sweden.^5^Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Médecine Moléculaire de Rangueil, Toulouse, France.

Heightened serotonin (5HT) signaling is postulated in the development and/or progression of myxomatous mitral valve disease (MMVD) in dogs. Little is known regarding platelet, myocardial, or valvular 5HT concentration (\[5HT\]) in affected dogs. We sought to quantify \[5HT\] in platelet‐rich (PRP), platelet‐poor plasma (PPP), left ventricular myocardium (LV), and mitral valve leaflet tissue (MV) using HPLC. PPP/PRP was prepared from 45 dogs comprising 4 different plasma groups (pG1, healthy non‐Cavalier King Charles Spaniels \[CKCS\], n = 8; pG2, healthy CKCS, n = 12; pG3, MMVD CKCS, n = 14; pG4, MMVD non‐CKCS, n = 11). PRP \[5HT\] was greater than PPP \[5HT\] (P \< 0.0001) indicating platelets as the primary source of circulating 5HT. Median PRP platelet \[5HT\] was significantly different between groups (P = 0.003). PRP \[5HT\] was greater in pG2 (1.83 femtograms/platelet\[range,0.2‐4.76\];P = 0.002), pG3 (1.58,0.70‐4.03;P = 0.005), and pG4 (1.72,0.85‐4.44;P = 0.003) vs. pG1 (0.915,0.63‐1.3). There was no significant difference in median PPP \[5HT\] between groups. At euthanasia, LV and MV tissue was obtained from 24 dogs comprising 3 different tissue groups (tG1, MMVD, n = 8; tG2, dilated cardiomyopathy \[DCM\]/arrhythmogenic right ventricular cardiomyopathy \[ARVC\], n = 7; tG3, extra‐cardiac disease, n = 9). Median LV \[5HT\] was significantly different (P = 0.0024) between groups. LV \[5HT\] was higher in tG1 (11.8 ng/mg,3.96‐104.83) vs. tG2 (0.87,0‐10.1;P = 0.011) and vs. tG3 (2.46,0‐6.94;P = 0.001). MV \[5HT\] was significantly different between groups (P = 0.033) namely between tG1(32.4 ng/mg,8.36‐106.73) vs. tG3(3.59,0‐28.26;P = 0.01). In conclusion, platelet \[5HT\] was elevated in healthy and MMVD CKCS compared to healthy non‐CKCS. LV \[5HT\] was elevated in MMVD compared to DCM/ARVC or non‐cardiac disease. MV \[5HT\] was elevated in MMVD compared to non‐cardiac disease.

NOVEL VASODILATOR PROTOTYPE DRUG (LASSBio 897) AND ITS ACTION ON THE CARDIOVASCULAR SYSTEM OF DOGS {#jvim12375-sec-0006}
--------------------------------------------------------------------------------------------------

**P.R. Nasciutti^1^, I.P. Bittar^1^, A.R. Fayad^1^, F.O. Carvalho^1^, V. De Oliveira^1^, A.B. Fraga^2^, E.J. Barreiro^2^, [R. Oliveira Alves]{.ul}^1^**

^1^School of Veterinary and Animal Science, Federal University of Goiás, Brazil.^2^Federal University of Rio de Janeiro, Brazil.

LASSBio 897 is a new prototype drug produced from safrole substrate, a compound extracted from the "sassafras oil", found in Brazilian plants like "canela‐branca" (*Ocotea pretiosa*) which showed vasodilatory effects in *in vitro* (aorta of normotensive rats) and *in vivo* tests (rats). It was developed by Evaluation and Synthesis of Bioactive Substances Laboratory (LASSBio^®^) from Federal University of Rio de Janeiro. It is believed that the mechanism of action is mediated by muscarinic receptors with subsequent activation of the nitric oxide/cyclic guanosine monophosphate. Due to its pharmacological profile and the possibility of a new therapeutic strategy, an investigation of the effects on the cardiovascular system of dogs was held.

Thus, six adult Beagles, five females and one male, healthy, were used. All dogs were subjected to four treatments, with biweekly intervals, receiving, orally, specific doses of 0.5 mg/kg, 1.0 mg/kg and 2.0 mg/kg of LASSBio 897 and 0.5 mg/kg of benazepril, as positive control. The dogs underwent blood and urine sampling (before and twelve hours after oral administration of the prototype), Doppler echocardiographic and electrocardiographic examinations (before and one, two, four, six and twelve hours after oral administration) and blood pressure screening (before and fifteen, thirty, sixty and ninety minutes, two, four, six and twelve hours after administration).

The dogs showed no clinical or behavioral changes during the study. Regarding urinary, hematological and serum biochemical evaluations, although statistical differences between times were observed, the parameters remained within the reference values for the species, similar to the results obtained by Pereira et al. (2005) in a study administering benazepril. No dog had heart rhythm abnormalities. In Doppler echocardiographic evaluation, values obtained for stroke volume (SV) and cardiac output (CO) were lower than that described as normal for dogs, with the lowest values found after four (SV: 14.57 mL; CO: 1.26 L/min) and six (SV: 16.39 mL; CO: 1.34 L/min) hours of administration. In the assessment of systolic blood pressure, a decrease was observed after two hours (p = 0.009), for all three doses of LASSBio 897 administered, similar to the results obtained with administration of benazepril, demonstrating the molecule\'s potential vasodilatory activity in addition to its safety, since no hypotension occurred.

Considering the results obtained and the conditions under which this experiment was conducted, it can be concluded that the oral administration of LASSBio 897 in doses of 0.5 mg/kg, 1.0 mg/kg, 2.0 mg/kg did not cause side effects in healthy Beagles, demonstrating that the prototype drug is safe. All doses caused vasodilation after two hours of their administration, similar to what was observed with benazepril, a drug extensively used to treat hypertension in dogs.

THE INFLUENCE OF AGE AND SYSTEMIC DISEASES ON CARDIAC INFLAMMATION AND REMODELING IN CATS {#jvim12375-sec-0008}
-----------------------------------------------------------------------------------------

**[S. Fonfara]{.ul}^1,2^, U. Hetzel^2,3^, S. Hahn^2^, A. Kipar^2,3^**

^1^University of Bristol, Bristol, UK.^2^University of Helsinki, Helsinki, Finland.^3^University of Zurich, Zurich, Switzerland.

Little is known about the role of myocardial inflammation and remodeling in cardiac dysfunction, in particular in association with systemic diseases and aging.

Myocardial samples (interventricular septum, right and left atrium and ventricle) of 20 cats with systemic diseases (group 1), 10 cats with FIP (group 2), 7 cats with cardiac diseases (group 3), and 8 cats without systemic or cardiac diseases (group 4) were collected. Cats from groups 1 and 4 were additionally separated into age groups (\<5, 5‐10, \>10‐15 and \>15 years of age). Transcription levels of feline interleukin (IL)‐1, IL‐2, IL‐4, IL‐6, IL‐18, tumour necrosis factor‐α (TNF), interferon‐γ (IFN), transforming growth factor‐β (TGF), matrix metalloproteinase (MMP)‐2, MMP‐3, MMP‐13, tissue inhibitors of metalloproteinase (TIMP)‐1, TIMP‐2, TIMP‐3 were analysed in relation to the house keeping gene GAPDH, using real time RT‐PCR.

Transcription of IL‐4, IFN, MMP‐2, MMP‐3, MMP‐13 was highest in group 2 (p \< 0.038), and of IL‐1, IL‐6, TNF, TGF, TIMP‐1, TIMP‐3 in groups 2 and 3 (p \< 0.001). IL‐18 and TIMP‐2 mRNA concentrations were not different between groups 1, 2, and 3, but higher than in group 4 (p \< 0.016). Regional differences in mRNA expression were detected in cats of groups 1, 2 and 4. Young cats showed higher transcription levels for IL‐1, IL‐2, IL‐4, IL‐6, MMP‐3 (p \< 0.003), whereas TGF increased with age (p = 0.036).

Myocardial mRNA expression of markers for inflammation and remodelling was similar in cats with systemic and cardiac diseases, which suggests an impact of systemic diseases on cardiac function. Furthermore, age might influence cardiac inflammation and remodelling.

MECHANISMS FOR SUDDEN CARDIAC DEATH IN ENDURANCE ATHLETES: SUPPORT FOR EXERCISE‐INDUCED ARRHYTHMOGENESIS {#jvim12375-sec-0010}
--------------------------------------------------------------------------------------------------------

**[S.A. Jesty]{.ul}, S.M. Johns, B. Potter, E. Berger, I.M. Asif**

University of Tennessee, Knoxville, TN.

The purpose of this study was to determine whether intensive exercise training in dogs leads to ventricular remodeling that increases susceptibility to malignant arrhythmias. Sudden cardiac death (SCD) is the leading cause of death during exertion in people, and occurs also in animal athletes such as horses and dogs. Unfortunately, the factors explaining this phenomenon are essentially unknown. Investigation is needed to understand the mechanisms of SCD during endurance activity in order to improve outcomes in both people and animals.

This was a repeated measures design pilot study of 5 laboratory Beagle dogs serving as their own controls. Each dog underwent baseline in vivo electrophysiologic (EP) testing to assess the susceptibility to triggered ectopic ventricular activity, participated in a 16 week exercise conditioning program (treadmill running, 4 days per week, up to 90 minutes per day, 4 mph, 13% grade), and then underwent a repeat in vivo EP test to assess the effect of endurance exercise on arrhythmia inducibility.

At baseline, 0/5 (0%) of the dogs had inducible arrhythmias during EP testing. After the 16 week exercise program, 4/5 (80%) of the dogs displayed clear inducible ventricular arrhythmias during EP testing; these triggered arrhythmias appeared to be of right ventricular origin.

Although there are clear benefits to moderate intensity exercise, intensive endurance exercise training may promote adverse cardiac remodeling that acts as a substrate for malignant arrhythmias. Further understanding of SCD mechanisms may lead to enhanced prevention and resuscitation strategies.

A CROSS‐SECTIONAL STUDY OF CARDIOMYOPATHY PREVALENCE IN 780 CATS IN REHOMING CENTERS (THE CATSCAN STUDY) {#jvim12375-sec-0012}
--------------------------------------------------------------------------------------------------------

**J.R. Payne, [V. Luis Fuentes]{.ul}, D.C. Brodbelt**

Royal Veterinary College, Hatfield, Hertfordshire, United Kingdom.

The prevalence of cardiac murmurs and hypertrophic cardiomyopathy (HCM) was investigated in cats in 2 rehoming centers over a 16 month period using auscultation and 2D echocardiography. HCM was defined as a diastolic left ventricular (LV) septal or free wall thickness ≥6 mm.

Cats were considered eligible if they were ≥6 m of age and excluded if hypertensive, hyperthyroid, pregnant, had any clinical signs, or were too nervous/aggressive to examine. One operator (JRP) auscultated, measured blood pressure, and scanned all cats.

Of 1007 eligible cats, 780 completed the protocol. Median (range) age group (categorical) was 1‐3 y (range 6‐12 m -- 17‐19 y); though 102 cats were ≥9 y and 9 cats were ≥15 y. Median (range) body weight was 3.7 (1.3‐7.9) kg; 43.4% were male, and 97.2% were non‐pedigree. A murmur was detected at first auscultation in 30.5% cats. A gallop was heard in 3 cats and an arrhythmia in 7 cats. HCM was diagnosed in 14.7%; 35.7% of which had systolic anterior motion of the mitral valve (SAM). Prevalence of HCM increased with age (p \< 0.001). The positive predictive values (PPV) of a murmur for detecting HCM on a single auscultation were 15.4% in juvenile cats (6‐12 m) and 54.2% in senior cats (≥9 y); the respective negative predictive values (NPV) were 97.1% and 79.2%.

Both murmurs and HCM are extremely common in the general cat population, but many cats with a murmur have normal wall thickness, particularly when young. The PPV of a murmur to indicate HCM, and HCM prevalence, both increase with age.

DOES PIMOBENDAN THERAPY FOR CANINE SECONDARY PULMONARY ARTERIAL HYPERTENSION ALTER TRANS‐SEMILUNAR VALVE SPECTRAL DOPPLER VARIABLES? {#jvim12375-sec-0014}
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**[D.G. Ohad]{.ul}, E. Gan‐Mor, Y. Golani, T. Bdolah‐Abram**

The Koret School of Veterinary Medicine, the Hebrew University of Jerusalem, Rehovot, Israel.

Pulmonary hypertension (PH) may be present but hard to quantify or even identify in the absence of tricuspid or pulmonary insufficiency. We sought to find measurable changes in Doppler parameters of systolic blood flow through the semilunar heart valves in dogs with PH secondary to mitral valve disease (MVD), with and without pimobendan therapy.

Data were retrospectively obtained from 186 consecutive MVD dogs examined between 2009 and 2011, with Doppler evidence of PH. Dogs were sorted into 2 groups based on whether (n = 96) or not (n = 90) pimobendan was included in their therapy.

Only in the absence of pimobendan therapy, aortic acceleration‐time (AccT), aortic ejection‐time (ET), and aortic AccT/ET decreased significantly over time, potentially due to a higher systemic afterload or a decreased cardiac output due to progressive PH. In dogs receiving pimobendan, pulmonary‐AccT, pulmonary‐ET, and pulmonary AccT/ET decreased to a lesser extent along time, than in dogs with no pimobendan therapy.

Nevertheless, pimobendan was not unequivocally proven to reduce right ventricular afterload as per spectral Doppler imaging. The reason may be the enhancement of right ventricular stroke volume following inodilation with reduced afterload, or the progressive nature of the underlying MVD along with its complications, including progressive PH. A larger, prospective study including ECG‐related systolic time intervals may establish whether the impedance to blood‐flow through each of the semilunar valves progresses or decreases over time, with and without therapy.

HYPERTROPHIC CARDIOMYOPATHY IN THE SPHYNX CAT: GENETIC ASPECTS, CLINICAL EVOLUTION, ECHOCARDIOGRAPHIC AND MORPHOMETRY FINDINGS: 172 CASES {#jvim12375-sec-0016}
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**[C. Amberger]{.ul}, E. Mottet, D. Brizard, S. Riesen, C. Lombard**

Imavet center, Geneva and Vetsuisse University, Berne, Switzerland.

Sphynx cats are predisposed to hypertrophic cardiomyopathy (HCM) with suspected autosomal dominant mode of inheritance (incomplete penetrance). The objective of this report is to characterize heart morphometry in Sphynx HCM based on a retrospective evaluation of 172 patients between 2003 and 2013. Echocardiographic measurements, clinical evolution, pedigree analysis and necropsy findings were evaluated. Based on normal values in the Sphynx, HCM was diagnosed by conventional echocardiography using 95% CI on both interventricular septum and free wall and mean + 2SD (6 mm) for the cut‐off limit between normal and HCM. 33/172 (19%) abnormal examination with a diagnosis of HCM were followed for 2 to 10 years. Age of affected cats ranged from 1 to 4 years (median 1.8). The age of onset of clinical signs ranged from 1 to 9 years (median 5). Echocardiographic morphometry of LV hypertrophy was confirmed by necropsy findings. Histological changes were similar to observations previously done in domestic shorthairs and Maine Coon cats. Signs of myocarditis have been found in two cats with acute congestive heart failure, both with a positive PCR for coronavirus.

Results of this report suggest an autosomal dominant mode of inheritance. 16/33 (48%) of HCM cats were diagnosed as equivocal (wall thickness between 4.5 mm (95% CI) and 6 mm) at the age of 18 month, and confirmed with developed HCM (\> 6 mm) at the age of 3 years. 29/33 cats are still alive 2 to 10 years after diagnosis, 15/33 (45% developed clinical symptoms with left atrial dilation), 4/33 (12%) died of heart failure and 14/33 (42%) remains asymptomatic.

CLINICOPATHOLOGIC FEATURES OF DOGS AND CATS PRESENTED TO A CARDIORESPIRATORY REFERRAL INSTITUTION DIAGNOSED WITH ACUTE TOXOPLASMOSIS {#jvim12375-sec-0018}
------------------------------------------------------------------------------------------------------------------------------------

**[N. Van Israël]{.ul}**

Animal CardioPulmonary Consultancy (ACAPULCO), Masta, Belgium.

Toxoplasma gondii infects nearly all warm‐blooded animals and the consequences of its passage in the intermediate (eg. dog) and definitive host (cat) have often been underestimated. The objective of this study was to retrospectively describe the clinical and pathological features, with an emphasis on the cardiorespiratory system, in a large population with naturally occurring Toxoplasmosis. Acute Toxoplasmosis was defined as animals having positive IgM titers or a fourfold seroconvalescence of IgG titers over a 3‐4 week period (as determined by IFA or ELISA techniques). Fourty‐seven dogs and 5 cats fulfilled the criteria. There was no specific breed or gender predisposition. The age range was wide (cats: 5‐14 y median 5.5 y; dogs: 4 m‐10 y median 4.8 y). Anorexia and lethargy were the main presenting signs in cats, were in dogs 61% were exercise intolerant, 53% experienced breathlessness, 23% coughed and 23% were syncopal. On electrocardiography AV‐block was present in 6 dogs (3 first, 1 second, 2 third degree), V‐arrhythmias in 9 dogs and supraventricular arrhythmias in 5 dogs (2 AF, 1 atrial flutter, 2 SVT). Radiographic findings ranged from pulmonary (broncho‐interstitial patterns (5) and alveolar 'aspiration' infiltrates (2)) to cardiac pathology (cardiomegaly (5) and congestive heart failure (3)) but was normal in 21/35 sets of RX available. Echocardiography was normal in 25/48 animals and showed signs that might have been consistent with myocarditis in only 9/48 animals. Two dogs had developed pericardial and one pleural effusion. A neutrophilia was the most frequent hematological abnormality (15%), followed by a mildly elevated HCT (11%). Elevated liver enzymes was the most common biochemical finding (35) followed by increased CPK in 5/52. Toxoplasmosis IgM titers at initial presentation (1/40‐1/640 median 1/60) were elevated in all but 1 cat that seroconverted (IgG) over a 3 week period. It could take up to 16 months for complete disappearance of the IgM titers with a median of 5 months. In two dogs the titers were re‐activated over time. Troponin I levels were available in 25 dogs and elevated in 10 (range 0.34‐14.5). Proteinuria at initial presentation was a feature in only 3 dogs and 1 cat. Final clinical diagnosis consisted of myocarditis in 17 animals, hepatopathy in 4, tracheobronchitis/pneumonitis/pneumonia in 7, pericarditis, chorioretinitis and PLNP in 2, laryngeal paralysis in 3 (accompanied with megaoesophagus in 2), pleuritis, polyarthritis, polymyopathy and sialodenitis respectively in 1. Nearly all animals were treated with clindamycine as first choice, S/TMP or doxycycline were the second choice. Three dogs died suddenly during their treatment and 9 were euthanized (3 cats) for complications of the disease, making this disease not as inoffensive as widely described.

COMPLICATIONS ASSOCIATED WITH TRANSCATHETER PDA OCCLUSION: RESULTS OF AN ACVIM CARDIOLOGY SURVEY {#jvim12375-sec-0020}
------------------------------------------------------------------------------------------------

**[S.G. Gordon]{.ul}^1,2^, A.B. Saunders^1,2^, R. Fries^1,2^, M.W. Miller^1,2^, M. Rishniw^3^**

The Michael E. DeBakey Institute, College of Veterinary Medicine and Biomedical Sciences^1^Texas A&M University, College Station, TX^2^Veterinary Information Network, Davis, CA^3^.

A variety of devices are used for transcatheter occlusion of patent ductus arteriosus (PDA) in veterinary medicine including various types of embolization coils, vascular plugs and occluders. Intra‐operative, immediate post‐operative and delayed (2 days post‐operatively) embolization to the systemic or pulmonary circulation is a reported complication of transcatheter PDA occlusion, regardless of the device type used. Embolization is typically thought to occur as a result of inappropriate device sizing or operator error. Veterinary studies assessing device efficacy and complication rates are relatively small making it statistically unlikely to catch rare, but important complications. This report is based on the results of a survey designed to assess type, rate and details of complications, including embolization, associated with transcatheter PDA occlusion. In addition we will report details of preferred methods of PDA size estimation, ductal occluder selection and procedural practices such as the use of transesophageal echocardiography. An initial survey of 77 respondents indicated that a variety of devices including the canine ductal occluder (69/77), coils (31/77), vascular plugs (20/77) have been used for transcatheter occlusion Preliminary Survey Results: Six of 385 (1.6%) procedures resulted in embolization. Five of the six were intra‐operative and one was after discharge from the hospital. Two of the six were in cats, and both of these devices were vascular plugs. The remaining devices were canine ductal occluders. There were two deaths. One death was associated with attempted retrieval of a vascular plug in a cat and the other a consequence of acute heart failure following delayed embolization of a ductal occluder. All respondents reported using fluoroscopy and angiography. In addition, transesophageal echocardiography was frequently used for adjunctive imaging during procedures.

DILATED CARDIOMYOPATHY IN STANDARD SCHNAUZERS WITH A HOMOZYGOUS 22 BP DELETION IN *RBM20* {#jvim12375-sec-0022}
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**[S.B. Leach]{.ul}^1^, [G.S. Johnson]{.ul}^1^, D. Gilliam^1^, M.W. Harmon^1^, T. Mhlanga‐Mutangadura^1^, L. Hansen^1^, J.F. Taylor^2^, R.D. Schnabel^2^**

^1^College of Veterinary Medicine, and^2^College of Agriculture, Food and Natural Resources, University of Missouri, Columbia, MO.

Our purpose was to characterize familial dilated cardiomyopathy (DCM) of Standard Schnauzers (SSs) and identify the causal mutation. Retrospective evaluation revealed DCM in 10 related SSs confirmed via echocardiography, necropsy, or both.

Examination of a 7‐generation pedigree containing all 10 DCM confirmed cases suggested an autosomal recessive mode of inheritance. A 30‐fold average coverage whole genome sequence (WGS) was generated with DNA from a male SS that died at 13.5 months of age with DCM and congestive heart failure. This WGS contained 69 homozygous sequence variants that were predicted to alter the primary structure of the gene product and absent from the WGSs of 101 canids not exhibiting DCM. A 22 bp deletion and frame shift in exon 11 of *RBM20* was the sequence variant considered most likely to be causal because mutations in human and rodent orthologs cause DCM. Eight confirmed DCM cases for which DNA was available all tested homozygous for the deletion allele (del/del). A prospective screen for the mutation identified 479 SSs that were homozygous for the wild type allele, 162 SSs that were heterozygous, and 6 additional SSs that were homozygous for the deletion allele. Two of these 6 del/del SSs have subsequently been diagnosed with occult DCM via echocardiography. Echocardiographic evaluation of 12 SSs that were heterozygous for the deletion allele, including a 15 year old SS, has revealed no echocardiographic evidence of myocardial dysfunction.

We conclude that the homozygous 22 bp deletion in *RBM20* is the likely cause of familial DCM in SSs.

COMPUTED TOMOGRAPHY ANGIOGRAPHY OF THE CORONARY ARTERIAL CIRCULATION OF BULLDOGS UNDER CONSCIOUS SEDATION IS FEASIBLE AND DEFINES ANOMALOUS ANATOMY {#jvim12375-sec-0024}
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**[B.A. Scansen]{.ul}^1^, G.A. Chiappone^2^, R. Layman^2^, R.D. White^2^**

^1^Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH.^2^Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH.

Single coronary artery anomaly (SCAA) has been recognized in bulldogs characterized by a prepulmonic course that limits the ability to intervene in the setting of pulmonary valve stenosis (PS). Standard of care to define coronary arterial anatomy requires left heart catheterization under general anesthesia. We investigated the ability of a new generation CT scanner to visualize the coronary arterial circulation of bulldogs under conscious sedation.

Ten bulldogs were prospectively enrolled, one with PS. Sedation included low‐dose dexmedetomidine and butorphanol to limit movement; atropine was administered as needed to normalize cycle length. The dogs were not intubated, remaining conscious during the imaging. Dogs were imaged with a dual‐source/128‐slice CT scanner ("Flash", Siemens Medical Systems, Erlangen, Germany); iodinated contrast (Isovue 370, 2 ml/kg) was delivered IV with the scan timed to peak aortic opacification. Structural and functional reconstructions were made of the left heart.

Visualization of the coronary circulation throughout the cardiac cycle was possible in all dogs even at heart rates of 180 per minute. SCAA with a prepulmonic left coronary artery was observed in a dog without PS. The coronary arterial anatomy of the dog with PS was clearly delineated and impacted catheterization planning.

We report a noninvasive protocol under conscious sedation for the determination of coronary arterial anatomy in a breed of dog at risk for SCAA. The existence of SCAA in an otherwise normal bulldog suggests SCAA may not be causative to the etiology of PS in bulldogs, as has been previously suggested.

CLATHRIN‐MEDIATED ENDOCYTOSIS IMPACTS CARDIAC OUTFLOW TRACT MORPHOGENESIS AND A SINGLE CODON INSERTION IN PHOSPHATIDYLINOSITOL BINDING CLATHRIN ASSEMBLY PROTEIN IS ASSOCIATED WITH NEWFOUNDLAND DOG SUBVALVULAR AORTIC STENOSIS {#jvim12375-sec-0026}
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**[J.A. Stern]{.ul}^1,2^, N.M. Nascone‐Yoder^3^, L.B. Lehmkuhl^4^, K.M. Meurs^2^**

^1^Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California Davis, Davis, CA.^2^Department of Veterinary Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.^3^Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.^4^MedVet Medical and Cancer Center for Pets, Worthington, OH.

Subvalvular aortic stenosis in Newfoundlands is described as a familial disease with an autosomal dominant pattern of inheritance, but no associated mutations have been reported.

More than 150 Newfoundland dogs were recruited for genetic studies of SAS. Dogs with left ventricular outflow tract (LVOT) velocities exceeding 2.5 m/sec were considered SAS affected and compared to controls with velocities \<1.8 m/sec. Fresh LVOT tissue was obtained from two severely affected Newfoundlands with SAS. RNA sequence analysis (RNAseq) was performed on the SAS tissue and 6 dog samples without SAS.

A single codon insertion was identified in Phosphatidylinositol binding clathrin assembly protein (PICALM) that segregates with disease status in Newfoundlands. Significant downstream structural change is predicted in the mutant PICALM protein. Loss of function is proposed as the insert centers over a breakpoint necessary for formation of PICALM fusion complex, a transcriptional regulator. The insertion was not identified in any control dogs (180) of varied breeds. PICALM is primarily involved in clathrin‐mediated endocytosis at the cellular membrane. Day 40 *Xenopus laevis* embryos were small molecule inhibited for clathrin and observed for abnormalities in outflow tract morphogenesis. Significant abnormalities in outflow tract morphogenesis were observed by immunohistochemistry.

A single codon insertion in PICALM alters the protein and is associated with SAS development in Newfoundlands. The role of PICALM in cardiac morphogenesis and pathogenesis is yet to be determined, however clathrin inhibition during embryogenesis as might be observed with a dysfunctional PICALM protein, demonstrated a previously unreported role for clathrin‐mediated endocytosis during outflow tract morphogenesis.

INVESTIGATION OF DIETARY FACTORS WITH POSSIBLE ASSOCIATIONS WITH CANINE DEGENERATIVE MITRAL VALVE DISEASE {#jvim12375-sec-0028}
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**J.L. Sauer, [L.M. Freeman]{.ul}, J.E. Rush**

Tufts Cummings School of Veterinary Medicine, North Grafton, MA.

The pathophysiologic cause of degenerative mitral valve disease (DMVD) remains unclear. Although there are a number of ways in which diet could play a role in DMVD, including the serotonin (5‐hydroxytryptamine \[5HT\]) pathway, dietary factors related to the development of DVMD have not been investigated. Therefore, the objective of this study was to measure dietary amino acids, choline, carnitine, serotonin, and ergovaline as possible factors that could play a role in the pathophysiology of DMVD. Thirteen commercially‐available diets were selected for analysis based on a previous study comparing dogs with and without DMVD and diet histories from clinical cases. Diets were analyzed for macronutrients; amino acids; ergovaline; the indoleamines, 5HT and melatonin; choline, and free L‐carnitine. There was a wide range in the concentrations of all analytes in the diets tested. No essential amino acids were below the Association of American Feed Control Officials (AAFCO) minimums. Taurine, although not an essential amino acid for dogs, was below the AAFCO Cat Food Nutrient Profile for taurine in 9 of 13 diets. Tryptophan ranged from 0.19‐0.59% dry matter (median = 0.28% dry matter). All 13 samples tested had undetectable ergovaline concentrations. One sample tested positive for 5HT, and melatonin was detected in 8 diets. There also was wide variation (3‐fold and \>100‐fold difference, respectively) in choline and free L‐carnitine concentrations among diets. Additional research is needed on the effects of varying dietary intake of tryptophan and other amino acids, 5HT, choline, and carnitine on cardiac valve metabolism.

BODY SIZE IS RELATED TO METABOLIC MARKERS AND LEFT VENTRICULAR HYPERTROPHY IN CATS {#jvim12375-sec-0030}
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**J.E. Rush, [L.M. Freeman]{.ul}, A. Feugier, I. van Hoek**

Tufts Cummings School of Veterinary Medicine, North Grafton, MA, USA and Royal Canin SAS, Aimargues, France.

Cats with hypertrophic cardiomyopathy (HCM) are larger and have higher insulin‐like growth factor‐1 (IGF‐1) concentrations than cats without HCM. To better understand the relationship between growth, body size, and HCM, the objective of this study was to assess adult cats to determine whether echocardiographic findings of left ventricular hypertrophy (LVH) are related to early growth patterns, body size, or metabolic markers. Adult cats from a single colony that were ≥ 3 years of age and for which growth curves were available were eligible for the study. Physical examination and echocardiography were performed, and body weight, body condition score (BCS), and head length and width were measured. Circulating glucose, insulin, N‐terminal pro‐B‐type natriuretic peptide (NT pro‐BNP), and IGF‐1 concentrations were measured and growth data were collected. Stepwise multivariate analysis of variance and multivariate logistic regression were performed. Twenty‐eight neutered adult cats (20 males, 8 females) were eligible for the study. Median age was 5.3 yrs (range, 3.2‐6.8 yrs). Current body condition scores ranged from 4‐9 (median, 5.5) and body weight ranged from 2.7‐7.2 kg (median, 4.8 kg). Cardiac abnormalities included a cardiac murmur (n = 7; 24%), gallop (n = 3; 10%), and arrhythmia (n = 1; 4%). Fourteen of 28 cats (50%) had echocardiographic evidence of left ventricular hypertrophy (LVH). Head width (*P *=* *0.017), body weight (*P *\<* *0.001), NT pro‐BNP (*P *=* *0.023), and IGF‐1 (*P *=* *0.013‐0.022) were significantly associated with measures of LVH. Potential associations between body size, IGF‐1, LVH, and HCM warrant future prospective studies.

USEFULNESS OF PLASMA CONCENTRATION OF CHROMOGRANIN A AS AN INDICATOR OF SYMPATHETIC TONE IN DOGS WITH MYXOMATOUS MITRAL VALVE DISEASE {#jvim12375-sec-0032}
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**[K. Höglund]{.ul}^1^, M. Stridsberg^2^, O. Höglund^1^, A. Tidholm^3^, J. Häggström^1^, I. Ljungvall^1^**

^1^Swedish University of Agricultural Sciences, Uppsala, Sweden.^2^Dept of Medical Sciences, Uppsala University, Uppsala, Sweden.^3^Albano Animal Hospital, Danderyd, Sweden

Chromogranin A (CgA) is stored in secretory cells of sympathetic nerve endings and the adrenal medulla and is co‐released with catecholamines, while the CgA‐derived peptide Catestatin acts sympathoinhibitory. The stability of these molecules in plasma makes them interesting candidates for assessment of the sympathetic nervous system. In humans, CgA is also present in ventricular myocardium, co‐localized with B‐type natriuretic peptide (BNP). The aim of the study was to investigate whether plasma Catestatin concentration was associated with myxomatous mitral valve disease (MMVD) severity in dogs, and to assess potential associations between plasma Catestatin concentration and dog characteristics, echocardiographic variables, heart rate (HR), systolic blood pressure (SBP) and N‐terminal proBNP.

70 client‐owned dogs with MMVD of varying severity were prospectively recruited. Dogs were classified according to MMVD severity (healthy, or mild, moderate or severe disease). Three dogs were in decompensated congestive heart failure (CHF). Plasma concentration of Catestatin was analyzed using radioimmunoassay.

No association between Catestatin concentration and MMVD severity groups was found. HR was higher in severely affected dogs than healthy and mildly affected, but was not associated with Catestatin concentration. Very weak negative association with left atrial and ventricular size (R^2^ = 0.08, *P *=* *0.01 for both) and very weak positive association with SBP (R^2^ = 0.07, *P *=* *0.02) was found for Catestatin concentration, while remaining variables were non‐significant.

In the present study population, Catestatin was not associated with severity of MMVD and HR seemed to be a better indicator of sympathetic tone than Catestatin. Including more dogs in decompensated CHF might have given different results.

ASSESSMENT OF MULTIPLE ECHOCARDIOGRAPHIC PARAMETERS IN GOLDEN RETRIEVER DOGS WITH OR WITHOUT SUBAORTIC STENOSIS {#jvim12375-sec-0034}
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**[E. Côté]{.ul}^1^, M.C. Bélanger^2^, R. Vanderstichel^1^**

^1^Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE, Canada^2^Faculty of Veterinary Medicine, University of Montreal, St. Hyacinthe, QC, Canada.

Currently, a diagnosis of subaortic stenosis (SAS) in dogs principally relies on auscultation of a basilar systolic heart murmur and echocardiographic (echo) demonstration of abnormally high Doppler‐derived peak left ventricular outflow tract blood velocity (LVOT Vmax). This retrospective study sought to identify associations among echo determinations of LVOT Vmax, the presence of an abnormal aortoseptal angle (AoSA), and left ventricular subendocardial hyperechogenicity (LV S‐H), and to investigate a possible association between AoSA and a heart murmur of equal or greater intensity over the right heart base compared to the left.

Medical records of Golden Retrievers (GRs) seen at 1 institution^1^ were reviewed if 1) a complete echo was available as cine loops, 2) no cardiac disorder other than SAS was noted, and 3) heart murmur point of maximal intensity (PMI) was noted in the record by a cardiologist at the time of echo. AoSA and S‐H were determined post‐hoc. GRs with LVOT Vmax \<2.0 m/s were considered normal (GR‐WNL). GRs with LVOT Vmax ≥2.5 m/s and a systolic basilar heart murmur were considered to have SAS (GR‐SAS). GRs that were neither GR‐WNL nor GR‐SAS were considered equivocal. Regression analysis was used for investigating relationships between parameters.

Fifty‐four GRs met the entry criteria: 15 GR‐SAS, 26 GR‐WNL, and 13 equivocal. AoSA and LVOT Vmax were inversely associated: for each 1° increase in AoSA, LVOT Vmax decreased by 0.04 m/s (p = 0.049). Dogs with moderate LV S‐H had AoSA that was on average 10.2° less than dogs without LV S‐H (p = 0.03). There was a significant association between AoSA and heart murmur PMI being equally loud or louder on the right rather than the left (p = 0.011), with such dogs having an AoSA that was a mean of 15.7° less than dogs with murmur PMI on the left.

In this sample, associations existed among parameters and these associations may provide clinically useful information in addition to LVOT Vmax when evaluating GRs for SAS.

NEUROLOGY {#jvim12375-sec-0036}
=========

EVALUATION OF LACTATE DEHYDROGENASE AND CREATINE KINASE ACTIVITY IN CEREBROSPINAL FLUID OF DOGS WITH NEUROLOGICAL DISEASES {#jvim12375-sec-0037}
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**[A.V. Chen]{.ul}, S.A. Thomovsky, J. Brune, N. Boswell, J.C. Houle**

Washington State University College of Veterinary Medicine, Pullman, WA.

The diagnostic significance of cerebrospinal fluid (CSF) lactate dehydrogenase (LD) and creatine kinase (CK) activity have been relatively unexplored in veterinary medicine. CSF LD and CK activity have been shown to be useful for the diagnosis and prognosis of meningitis in humans. The purpose of this study is to determine total LD and CK activity and its isoenzyme distribution in the CSF of dogs with idiopathic epilepsy (IE), primary brain tumors (PBT) and meningitis.

A total of 11 dogs were enrolled in this pilot study and divided into three groups: IE (n = 4), PBT (n = 4), and meningitis (n = 3). CSF total LD and CK activity were measured spectrophotometrically and isoenzyme distribution was determined using gel electrophoresis and densitometric scanning. Mean total LD activity was 8, 12, 99.3 U/L for IE, PBT, and meningitis, respectively. Mean LD‐1 contribution was 59.7, 53.4, 11.2% while LD‐3 contribution was 14.6, 11.0 and 48.1% for IE, PBT and meningitis, respectively. Mean total CK activity was 4.3, 3.8, 22.7 U/L for IE, PBT, and meningitis, respectively. Mean CK‐MM contribution was 69.7, 63.8, and 24.4% while CK‐BB contribution was 21.5, 29.9 and 75.3% for IE, PBT and meningitis, respectively.

CSF total LD and CK activity were higher in meningitis dogs. These dogs had a suppression in LD‐1 with an increase in LD‐3 activity. CK‐BB was also the predominate isoenzyme in meningitis dogs while CK‐MM was the predominate isoenzyme in dogs with IE and PBT. LD and CK activity in canine CSF may be a useful diagnostic tool for distinguishing meningitis from other neurological diseases.

ANALYSIS OF CYTOKINE CONCENTRATIONS IN THE CEREBROSPINAL FLUID OF GREAT DANES WITH AND WITHOUT CLINICAL SIGNS OF CERVICAL SPONDYLOMYELOPATHY {#jvim12375-sec-0039}
--------------------------------------------------------------------------------------------------------------------------------------------

**[P. Martin‐Vaquero]{.ul}^1^, R.C. da Costa^1^, S.A. Moore^1^, A.C. Gross^2^, T.D. Eubank^2^**

^1^College of Veterinary Medicine, The Ohio State University, Columbus, OH.^2^Davis Heart & Lung Research Institute, The Ohio State University Medical Center, Columbus, OH.

The purpose of this study was to compare the cerebrospinal fluid (CSF) cytokine concentrations of Great Danes (GDs) with and without signs of cervical spondylomyelopathy (CSM). Associations between cytokine concentrations and administration of anti‐inflammatories, disease severity, severity of spinal cord (SC) compression, and presence of SC signal changes in the CSM‐affected GDs were also investigated.

Thirty client‐owned GDs were prospectively enrolled, 15 clinically normal and 15 CSM‐affected. All dogs underwent MRI of the cervical vertebral column and cerebellomedullary cistern CSF collection. Routine CSF analysis (total protein, cell counts) was performed. A commercially available canine multiplex immunoassay was used to measure concentrations of granulocyte macrophage colony‐stimulating factor (GM‐CSF), interferon‐gamma (IFN‐γ), inducible protein 10 (IP‐10), IL‐2, IL‐6, IL‐7, IL‐8, IL‐10, IL‐15, IL‐18, keratinocyte‐derived cytokine (KC‐like), monocyte chemoattractant protein‐1 (MCP‐1), and tumor necrosis factor‐α (TNF‐α). Linear regression analysis was used to compare cytokine concentrations between groups, and to test for associations with the use of anti‐inflammatories, severity of signs and SC compression, and SC signal changes in the affected GDs.

There were no significant differences between normal and affected GDs in the routine CSF analysis, and concentrations of IL‐6, KC‐like, and IL‐10. CSM‐affected GDs had significantly lower concentrations of MCP‐1 than normal GDs (*P *=* *0.028). Moreover, affected GDs with severe (*P *=* *0.002) and moderate (*P *=* *0.022) SC compression on MRI had significantly lower MCP‐1 concentrations than those with mild SC compression. There were no associations between cytokine concentrations and use of anti‐inflammatories or disease severity in the affected GDs. Concentrations of IL‐6 were significantly higher (*P *\<* *0.001) in GDs with SC signal changes. The remainder cytokines were below the detection limits.

Lower MCP‐1 concentrations in CSM‐affected GDs might interfere with monocyte attraction, slowing down the removal of myelin debris, and hindering axon regeneration and remyelination. Markedly higher CSF IL‐6 concentrations in CSM‐affected GDs with SC signal changes suggest more severe chronic inflammation in this subgroup of affected GDs. Histopathologic and immunohistochemical studies are needed to further evaluate the role of these cytokines in CSM.

ACCURACY OF PREPOPERATIVE COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING AS COMPARED TO SURGICAL FINDINGS IN CHONDRODYSTROPHIC DOGS WITH INTERVERTEBRAL DISC DISEASE {#jvim12375-sec-0041}
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Intervertebral disc disease is common in chondrodystrophic dogs. Computed tomography (CT) and Magnetic Resonance (MR) Imaging are commonly used to diagnose extruded intervertebral disc material (EIVDM). The purpose of this study is to evaluate the accuracy of MR and CT in diagnosing EIVDM in chondrodystrophic dogs with thoracolumbar disc disease as compared to intraoperative findings.

Thirty‐five chondrodystrophic dogs with thoracolumbar EIVDM who underwent advanced imaging and surgery were included in the study. MR, CT and hemilaminectomy surgery were performed on all dogs. Accuracy of CT and MR for location of EIVDM, identification of the disc from which herniation occurred, lateralization of EIVDM, distribution with respect to both the disc space and spinal cord, and length of EIVDM were compared to intra‐operative findings. Patient temperature loss and duration of each imaging procedure were also compared.

Accuracy of site of EIVDM was 90.6% for CT and 93.8% for MR. Accuracy of disc material lateralization was 84.4% for both modalities. Accuracy of the EIVDM distribution with respect to disc space was 71.9% for CT and 68.8% for MR; while it was 59.4% for CT and 46.9% for MR with respect to the spinal cord. All accuracy data is as compared to intra‐operative findings. On average, CT scanning took 14.2 minutes while MR was 64.2 minutes; temperature loss was 1.03° and 2.36° for CT and MR, respectively.

Both imaging modalities are comparable in the diagnosis and description of thoracolumbar EIVDM. Temperature loss and scan duration are significantly less in CT as compared to MR.

SERUM PHENOBARBITAL LEVELS IN CATS FOLLOWING CHRONIC TRANSDERMAL ADMINISTRATION {#jvim12375-sec-0043}
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**J. Delamaide Gasper, [H.L. Barnes Heller]{.ul}, L. Trepanier, M. Robertson**

University of Wisconsin, Madison, WI.

The purpose of this study was to determine if chronic transdermal phenobarbital (PB) administration achieved serum phenobarbital (S‐PB) concentrations between 15‐45 ug/mL in healthy cats. Nineteen healthy, staff and student owned cats were divided into 3 groups. Transdermal phenobarbital in pluronic lecithin organogel (PLO) (groups 1 and 2) or PCCA‐Lipoderm (Activemax^®^) (group 3) was applied to the pinnae for 14 days. Group 1 received 3 mg/kg q 12 hours, groups 2 and 3 received 9 mg/kg q 12 hr. Median S‐PB concentration on day 15 at times 0, 2, 4, and 6 hours post drug administration were 7.5 ug/mL, 6.5 ug/mL, 6.5 ug/mL, 6.0 ug/mL for group 1; 26.0 ug/mL, 26.0 ug/mL, 25.5 ug/mL, and 25.5 ug/mL group 2, and 17.0 ug/mL, 15.5 ug/mL, 15.0 ug/mL, and 15.5 ug/mL in group 3. One cat was withdrawn from group 2 on day 3 due to intolerable side effects. An additional cat was added to total 6 cats completing group 2. Side effects were mild and transient in 12 of the 18 (66%) cats completing the study. Side effects included polyuria, polydipsia, polyphagia, sedation, ataxia and mild paraparesis, pinnae erythema and increased ear grooming. The results of this study show that therapeutic serum phenobarbital concentrations can be achieved in cats, following chronic transdermal administration of PB in PLO and PCCA Lipoderm at 9 mg/kg q 12 h, and that side effects were minor.

VALIDATION AND PROGNOSTIC VALUE OF 2 NEW HEAD TRAUMA SCORING SYSTEMS IN 84 DOGS {#jvim12375-sec-0045}
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**[S.R. Platt]{.ul}^1^, E. Beltran^2^, C. May^1^, D. Keys^1^, L. De Risio^2^, A. Haley^1^, M. Kent^1^, M. Perez^3^, A. Shores^3^**

^1^College of Veterinary Medicine, University of Georgia, USA;^2^Animal Health Trust, Newmarket, England, UK;^3^College of Veterinary Medicine, Mississippi State University.

An ideal coma scoring system or scale would be reliable, valid, linear and easy to use. Scoring systems are used objectively to decide the proper course of treatment, to monitor the success of therapy and provide an estimated prognosis. The modified Glasgow coma scale (MGCS) was developed 25 years ago as a guide for management and to assist in determining the prognosis for canine and felines with head trauma (HT) Although validated and statistically relevant, the MGCS is not linear, not always easy to use, nor entirely representative of the clinical presentations seen in veterinary medicine. To address these concerns, we proposed to amend the MGCS and evaluate the validity and prognostic value of 2 derivations of this current scale. Further, we aimed to use the retrospective validation of the new scales to determine sample size necessary for a prospective multicenter treatment study.

The MGCS was amended into 2 separate scoring systems, maintaining the 3 subdivisions of brainstem reflexes, motor function and consciousness. A minimized scale (Veterinary Cranial Injury Score; VCIS) assigned each subdivision 3 points; a more expansive scale (Small Animal Coma Score; SACS) totaled 17 points; low scores indicated severe dysfunction. We retrospectively scored dogs presented to one of three referral institutions subsequent to HT. A 4‐point outcome scale was developed based on the assessed quality of life (QOL) for all survivors. Data used in the study was obtained from medical records and included neurological exam, heart rate, temperature, and blood chemistry in all cases. All analyses were performed using SAS V 9.2; all tests were 2‐sided and the significance level was set at 0.05. Power analyses were performed using nQuery 4.0.

Eighty‐four dogs were evaluated. The mean MGCS scores and mean blood glucose values were significantly higher in dogs that survived to 72 hours. There were significant positive correlations of MGCS (r = 0.69), SACS (r = 0.68), VCIS (r = 0.59), temperature (r = 0.58) and heart rate (r = 0.36) with QOL scores at 1 month. There were significant positive correlations of MGCS (r = 0.57), SACS (r = 0.58), VCIS (r = 0.59), and temperature (r = 0.42) with QOL scores at 3 months. MGCS presentation scores were positively correlated with SACS (r = 0.93, p \< 0.0001) and VCIS (r = 0.82, p \< 0.0001) scores. Sample sizes calculated for a prospective treatment study were a total of 230 animals for SACS and 157 animals for VCIS.

This study validated 2 new scoring systems as having prognostic value in dogs with HT. The new clinical outcome score can be used to assess dogs at 1 and 3 months after the trauma in terms of their QOL. Information derived from this study is being used in the initiation of a prospective multi‐centered treatment trial using the power analysis results confirming feasible sample sizes.

DIFFUSION TENSOR IMAGING IN DOGS WITH AND WITHOUT CERVICAL SPONDYLOMYELOPATHY {#jvim12375-sec-0047}
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**[R.C. da Costa]{.ul}^1^, J. Armstrong^1^, S. Choi^2^, P. Martin‐Vaquero^1^, B. Dewey^3^, S. Smith^3^**

^1^Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH^2^Department of Radiology, The Ohio State University Medical Center, Columbus, OH, and^3^Institute of Imaging Science, School of Medicine, Vanderbilt University, Nashville, TN.

Cervical spondylomyelopathy (CSM) is the most common disease of the cervical spine of large and giant breed dogs. There is a limited understanding of the disease mechanisms and a lack of clearly defined outcome measures or prognostic indicators. Despite a large variety of surgical techniques available to treat CSM, long‐term survival of affected dogs needs to be improved. Diffusion tensor imaging (DTI), an advanced magnetic resonance imaging (MRI) technique recently applied to humans, is sensitive to changes in tissue microstructure and could yield prognostic information. This study aimed at evaluating changes in fractional anisotropy (FA), median diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AD) between dogs with and without CSM. We hypothesized that DTI differences would exist in CSM‐affected dogs compared to unaffected dogs, furthering the understanding of the disease mechanisms.

Fourteen control and 14 CSM‐affected Great Danes were enrolled for analysis with a novel DTI protocol optimized for the canine cervical vertebral column. All dogs underwent a 3.0 T MRI protocol of T1‐ and T2‐weighted images in the sagittal and transverse planes, and a DTI protocol consisting of single‐shot spin‐echo echo‐planar imaging with a repetition time (TR) of 24415, echo time (TE) of 42 ms, 6 diffusion‐weighting directions, *b*‐values: 0 and 500 s/mm^2^, and slice thickness of 5 mm with no gap. Post‐processing using purpose‐designed proprietary software generated tensor estimation and parametric maps. Using DTI Studio\'s ROI Editor, FA, MD, RD, and AD were measured from 3 transverse DTI slice segments over each disc region (C2‐C7). Sagittal and transverse T1 and T2 weighted images of CSM‐affected dogs were also evaluated for spinal cord signal changes.

Random‐effects linear regression analysis demonstrated significant differences in FA and RD (*P *\<* *0.05) between dogs with and without CSM, and no significant differences in MD and AD (*P *\>* *0.05). In CSM‐affected dogs, significant differences were identified for FA, RD, and AD when comparing the sites with and without signal changes at the C5‐C6 intervertebral space.

The FA and RD differences suggest that demyelination and loss of axonal integrity are present in spinal cords of CSM‐affected dogs. The evaluation of spinal cord microstructure with DTI yields information that could assist in the treatment and prognostication of CSM‐affected dogs.

ATLANTOAXIAL INSTABILITY WITH INCONGRUENCE: MRI FINDINGS AND SURGICAL TREATMENT IN 5 DOGS {#jvim12375-sec-0049}
-----------------------------------------------------------------------------------------

**[M. Dolera]{.ul}, L. Malfassi**

La Cittadina Fondazione Studi e Ricerche Veterinarie, Romanengo (CR), Italy.

Atlantoaxial instability is a surgical condition frequently described in toy breed\'s dogs. Various correction techniques has been described in veterinary literature. Aim of this study is to describe MRI‐CT imaging findings and a novel surgical technique for stabilisation of atlantoaxial instability associated with incongruence of atlantoaxial joint in dogs.

Five dogs with a body weight of 2 kg or less with atlantoaxial instability associated with articular incongruence were considered. At clinical examination all dogs showed tetraparesis and ataxia. At CT and MRI, the articular surface of the atlas was larger then the articular surface of the axis, a laxity of all atlantoaxial ligaments was evident, so during head and neck flexion the axis was dislocated dorsally and cranially into the spinal canal. Spinal cord showed chronic compression, with focal hyperintensity in seq TSE T2W and various degrees of syringomyelia. For surgery, the anaesthetised dogs were positioned in ventral recumbency, with the head extended on the neck with slight linear traction applied at maxillary canine teeth. The reduction of atlantoaxial subluxation was verified trough fluoroscopy. A standard dorsal approach to the atlas and axis was made. Two 2.7 mm self tapping cortical screws were inserted on atlas winds on each side in a dorsal‐ventral direction. Three 2.0 mm self tapping cortical screws were inserted transversally in the dorsal process of the axis. All screws were fused with polymethylmethacrylate. Serial clinical and imaging controls were made.

No intra‐operative complications were observed. Functional improvement occurred in all dogs. Serial CT examinations showed a stable reduction of dorsal and cranial axis dislocation, with persistence of a residual mild spinal compression due to different size of the articular surfaces of atlas and axis.

Several means for stabilisation of atlantoaxial dislocation are described in veterinary literature. Standard treatment consist in ventral arthrodesis with cross pinning, transarticular lag screw fixation or vertebral plating. This technique requires atlantoaxial joint congruence, otherwise the means of synthesis can injure the spinal cord. Dorsal techniques utilise various non‐absorbable suture materials or devices, such Kishigami Tension Band. However, cranial dislocation or impingement of the axis on spinal cord are not adequately counteracted. The technique that we describe is simple and safe and can be useful in surgical treatment in dogs with atlantoaxial dislocation and articular incongruence, a condition resembling atlantoaxial invagination described in human medicine.

CERVICAL DISC ARTHROPLASTY IN DOGS WITH DISC ASSOCIATED WOBBLER SYNDROME ‐ LIMITATIONS AND HOW TO PREVENT POSSIBLE COMPLICATIONS {#jvim12375-sec-0051}
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This study evaluated the limitations and the complications of the cervical disc arthroplasty (CDA) technique using the Adamo Spinal Disc^®^ in dogs with disc associated wobbler syndrome (DAWS).

Thirty‐three consecutive dogs with over 2 months history of DAWS diagnosed by MRI or CT‐myelography were evaluated. Nineteen dogs were treated for a single level lesion, eleven dogs for a two level lesion, and three dogs for a three level lesion, for a total of a 50 treated disc sites. Median follow‐up time was 12 months (range 2 weeks to 42 months). At the time of this writing, twenty‐six dogs were still alive and seven dogs were deceased (five of them for non neurological diseases).

One dog (12.4 year‐old, Sheltie‐mix weighing 19.5 lb), was euthanized 2 weeks post‐surgery, because of compressive fracture of C6 with ventral displacement of the implant. Two of the three dogs presenting with over 4 months of non‐ambulatory tetraparesis and severe extensor rigidity in both front legs had a poor outcome. In one dog, excessive burring of the vertebral end plate caused immediate subsidence. In two dogs, a vertebral fracture fissure occurred in surgery during distraction, this did not affect the clinical outcome. In 7 out of 50 sites (14%) subsidence was observed, this was mostly seen when narrow (side‐to‐side) and/or thicker (cranial to caudal) implants were used. Subsidence, except for one dog, did not affect the clinical outcome.

Correct patient selection (dog size and neurological status), size of the implant, endplate preparation, and applied distraction during surgery need to be considered as important factors that may influence the outcome.

A PILOT STUDY OF LEVETIRACETAM PULSE THERAPY FOR CANINE CLUSTER SEIZURES {#jvim12375-sec-0055}
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**[R. Timothy Bentley]{.ul}, M. Logan, A. Sangster, G.E. Moore**
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Canine pharamacoresistant epilepsy is common, and most pharmacoresistant dogs suffer from cluster seizures. This can lead to increased hospitalization, owner frustration and euthanasia. Levetiracetam has been proposed to be more efficacious when given intermittently than continuously. A double‐blind, placebo‐controlled, crossover pilot study was performed in six out‐patient dogs with idiopathic epilepsy, continuing to have cluster seizures despite receiving any two maintenance anti‐convulsant drugs other than levetiracetam at therapeutic serum concentrations. Dogs were randomized to a levetiracetam period (3‐4 months) followed by an equal length placebo period or vice‐versa, and received the same maintenance anti‐convulsants throughout. The levetiracetam dose was 30 mg/kg, compounded into capsules. Placebo capsules were identical in appearance. The owners started the study drug following a seizure. The owners then continued to give the study drug every 8 hours until the dog had gone 24 hours without any seizures, then stopped until the next seizure.

Dogs receiving levetiracetam pulse therapy had a median of 1 seizure per cluster (range 0‐2) compared to placebo therapy (median of 4 seizures per cluster, range 1‐7) (*P *=* *0.052). More dogs met pre‐determined treatment failure criteria during the placebo period (n = 3) than the levetiracetam period (n = 1). Serum concentrations of phenobarbital and potassium bromide were generally lower for the levetiracetam period than the placebo period, although this was not statistically significantly different (*P *≥* *0.075). Levetiracetam pulse therapy for cluster seizures, begun after the first seizure and continued until 24 hours without seizures, is probably effective in idiopathic epileptic dogs and warrants further investigation.

RELATIONSHIP OF DORSAL ATLANTOAXIAL JUNCTION COMPRESSIVE LESIONS (DURAL BANDS) TO CLINICAL SIGNS AND SYRINGOMYELIA IN CAVALIER KING CHARLES SPANIELS {#jvim12375-sec-0056}
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Dorsal compressive lesions at the atlantoaxial junction (i.e. dural bands) are a well‐recognized craniocervical junction anomaly, frequently seen alongside other craniocervical junction anomalies such as Chiari‐like malformations. Despite their regular identification on imaging, their clinical significance remains unclear. To address this, the authors investigated their influence on clinical status and on syringomyelia in a commonly affected breed.

Thirty‐six Cavalier King Charles spaniels (CKCS) were assessed for neuropathic pain and neurologic dysfunction, and were assigned a neurologic grade. Magnetic resonance imaging of the craniocervical junction was performed, with the head and neck straight and flexed. Imaging studies were then assessed for a dural band, a Chiari‐like malformation (CM), and syringomyelia. Dural band and syringomyelia severity was determined using both a compression index (objective) and grading (subjective), respectively.

Of the 36 CKCS imaged, 20 demonstrated neuropathic pain. Dural bands were present in 31/36 (83.8%) dogs; 34 had a CM. Syringomyelia was found in 23 (56.8%) dogs, 21 of which also had a dural band. Dural bands were associated with both the presence and severity of clinical signs, and the presence of syringomyelia. Higher compression indices were associated with more severe syringomyelia.

Dural bands appear to play a significant clinical role. Compression indices provide a better assessment of dural band severity compared to grading.

IDENTIFICATION OF A GLIOMA SUSCEPTIBILITY LOCUS IN DOGS {#jvim12375-sec-0058}
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Gliomas are devastating primary brain tumors that are highly overrepresented in ancestral Bulldog‐type breeds such as the Boxer, Bulldog and Boston Terrier, but not in other brachycephalic breeds such as the Pug. We hypothesized that across‐breed genome‐wide association mapping using these breeds would identify genetic susceptibility risk factors for the development of glioma.

Across‐breed genome‐wide association was performed for primary gliomas using the Illumina 170K canine SNP array with 40 cases and 142 controls. Targeted resequencing of control and glioma samples was performed to identify variants in glioma associated regions and putative disease causing mutations. Semi‐quantitative RT‐PCR, western blotting and functional analyses were performed to investigate candidate genes.

A significant association was identified on CFA 26 and appeared to be due to the oligodendroglioma cases. Across breed mapping carries with it significant population stratification but the magnitude of the effect of this association was compelling (Bonferoni *p = *2 X 10^‐34^). A haplotype was identified that was homozygous within breeds with high prevalence of glioma and segregated in a number of other breeds. Three candidate genes were identified with documented interactions with potential glioma pathways. Differential transcript expression was present in 2 genes comparing tumor tissue and normal brain. One candidate gene had a non‐synonymous exonic single nucleotide polymorphism that results in a decrease in gene function of approximately 50%.

We have identified potential susceptibility genes for glioma that may provide insight into gliomagenesis as well as providing possible targeted therapeutic and breeding strategies for prevention and treatment of gliomas.

CANINE AWAKE AMBULATORY WIRELESS VIDEO ELECTROENCEPHALOGRAPHY {#jvim12375-sec-0060}
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Canines often present transient paroxysmal events that are hard to confirm as seizures based on description or observation alone. Electroencephalography (EEG) correlation between clinical manifestations and epileptiform activity allows this confirmation. However, sedation or general anesthesia during EEG recording may abolish the events of interest. This retrospective case series describes a novel canine awake ambulatory wireless video EEG technique.

All dogs investigated for possible seizure activity were selected from EEG cases recorded with the technique between July 2013 and March 2014, resulting in 20 cases. Subcutaneous needle or wire electrodes were affixed to the scalp by sticky bandage. If sedation was required for electrode placement, either dexmedetomidine was used and subsequently reversed with atipamezole (n = 4) or electrodes were placed during recovery from general anesthesia for other procedures (n = 2) with recording beginning after recovery and no further administration of sedatives. Up to fourteen electrodes were placed per dog, including ground and reference. Impedance was kept below 30 kOhms (ideally below 16 kOhms) where possible (replacing electrodes if necessary). Recordings were performed using a Lifelines Trackit EEG machine and reviewed using Persyst software. Recording length ranged from one to twelve hours. One dog was recorded twice, in two separate sessions. Recording took place in the clinic either as an outpatient or as an inpatient in the intensive care unit, with one dog additionally recorded at home.

Transient paroxysmal events investigated included tonic‐clonic seizures (n = 6), altered mentation / focal twitching (n = 6), tail‐chasing (n = 7), and head bobbing (n = 1). Paroxysmal epileptiform EEG activity confirmed three dogs as having seizures. Not all electrical seizures were accompanied by visible motor manifestations. Transient paroxysmal episodes were also recorded on video with no accompanying epileptiform EEG activity (n = 6). For 11 dogs, the transient episodes of interest did not occur during the recording period.

Awake ambulatory wireless video EEG can be helpful in diagnosis for 45% (9/20) of cases, similar to diagnostic yields reported in human pediatric EEG. This technique should be considered in canines presenting with frequent paroxysmal events of unknown origin.

PHARMACOKINETICS OF LEVETIRACETAM IN EPILEPTIC DOGS WHEN ADMINISTERED CONCURRENTLY WITH PHENOBARBITAL, BROMIDE, OR PHENOBARBITAL AND BROMIDE IN COMBINATION {#jvim12375-sec-0062}
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Levetiracetam (LEV) is a common add‐on antiepileptic medication (AED) for dogs with refractory seizures. Concurrent phenobarbital administration alters the disposition of LEV in healthy dogs. The objective of this study was to evaluate the pharmacokinetics of LEV in epileptic dogs when administered concurrently with conventional AEDs. Eighteen client‐owned dogs on maintenance therapy with LEV and phenobarbital (PB group, n = 6), LEV and bromide (BR group, n = 6) or LEV, phenobarbital and bromide (PB‐BR group, n = 6) were enrolled. All AEDs had attained steady state concentrations. Blood samples were collected at 0, 1, 2, 4 and 6 hours after a morning dose of LEV. Plasma LEV concentrations were determined by high‐pressure liquid chromatography. To account for dose differences among dogs, LEV concentrations were normalized to the mean study dose (26.4 mg/kg). Pharmacokinetic analysis was performed on adjusted concentrations using a noncompartmental method, and AUC calculated using the trapezoidal method. Compared to the PB and PB‐BR groups, the BR group had significantly higher Cmax (70.6 ± 24.0 μg/mL, versus 35.5 ± 13.7 μg/mL and 25.3 ± 9.0 μg/mL, respectively) and AUC0‐Cn (314.2 ± 114.3 h\*μg/mL versus 127.0 ± 64.7 h\*μg/mL and 91.0 ± 42.2 h\*μg/mL, respectively), and significantly lower CL/F (68.9 ± 22.1 mL/h/kg versus 172.1 ± 81.9 mL/h/kg and 247.6 ± 126.9 mL/h/kg, respectively). Concurrent administration of phenobarbital alone or in combination with bromide significantly alters the disposition of LEV in epileptic dogs compared to concurrent administration of bromide alone. These findings warrant consideration when utilizing LEV for add‐on therapy in dogs with epilepsy.

CHARACTERISATION OF GENE EXPRESSION IN NATURALLY OCCURRING FELINE DEGENERATIVE JOINT DISEASE ASSOCIATED PAIN {#jvim12375-sec-0064}
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Degenerative joint disease (DJD) associated‐pain is a clinically relevant and common condition affecting domesticated cats and other species including humans. Identification of the neurobiological signature of pain is well developed in pain models in rodents however this information is lacking from animals or humans with naturally occurring painful conditions. In this study, identification of housekeeping genes (HKG) for neuronal tissue and expression levels of genes considered associated with chronic pain in rodent models were explored in cats with naturally occurring osteoarthritic pain.

Eighteen adult cats were evaluated -- 9 normal, and 9 with hind limb radiographic DJD. Expression of pain signaling genes (including *Nav1.7*,*Nav1.9*,*NGF, NK1, TNF*α*, TrkA, ASIC3, COX2, Nav1.8, CX3CL1, ATF3*) in lumbar spinal cord dorsal horn, lumbar dorsal root ganglia and joint capsule tissues from normal and DJD‐animals were studied using quantitative RT‐PCR (qPCR).

HKG identified as the most stable across all tissue samples were many of the ribosomal protein genes, such as *RPL30* and *RPS19*. qPCR results showed downregulation of *COX‐2*,*NGF* and upregulation of *TNF*α genes in spinal cord and downregulation of *TNF*α in dorsal root ganglia collected from DJD‐animals. No genes were differentially expressed in the joint capsule samples due to high levels of variability in the healthy samples.

Several genes expected to be upregulated, based on results in rodent models, were downregulated. Further work is needed to understand the neurobiology of pain in naturally occurring disease and what rodent models are predictive of these changes in naturally occurring clinical pain conditions.

CONVECTION ENHANCED DELIVERY OF CETUXIMAB CONJUGATED WITH IRON OXIDE NANOPARTICLES FOR CANINE INTRACRANIAL GLIOMAS: A PILOT STUDY {#jvim12375-sec-0066}
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Convection enhanced delivery (CED) allows targeted treatment of intracranial neoplasia overcoming the restrictions of the blood brain barrier. The aim of this study was to evaluate the safety and efficacy of CED of cetuximab, an antibody against epidermal growth factor receptor (EGFR), for the adjunctive treatment of intracranial gliomas in dogs.

Nine dogs with intracranial gliomas were included. All dogs underwent surgical debulking of the tumor with intraoperative histopathologic confirmation. Two CED catheters were placed within the tumor cavity and attached to a Medtronic titanium SynchronoMed II pump containing bioconjugated cetuximab‐iron oxide nanoparticles (IONPs). The pumps were secured to the head or body of the dogs during recovery and set to infuse at 0.5 μl/min over 72 hours.

The 9 dogs included 2 Boxers, 3 Boston Terriers, one Pit Bull, one French Bulldog, one English Bulldog and a mixed breed. Clinical signs included seizures (8/9), circling (3/9), and mentation changes (4/9). All tumors were supratentorial and 8/9 were oligodendrogliomas (1 astrocytoma). MRI was performed at the following time points if the patients were alive: 24 hours, 7 days, 4 weeks, 6 months, 1 year, and 2 years. No side effects of the drug delivery post‐craniectomy were noted. MRI at 24 hours confirmed catheter placement and IONP presence in the tumor bed in all cases. At the time of writing, 4/9 dogs were still alive. Five dogs were euthanized because of recurrence of neurologic signs (circling, mentation changes) or seizures. Median survival time (MST) after surgery in the group of patients that were euthanized was 5.0 months (mean: 8.2 months; range 3 to 24 months) and current median survival time of those dogs which are still alive is 7.0 months (mean: 11.5 months; range 6‐26 months). Overall MST including surviving and euthanized patients was 6 months (mean: 9.2 months; range 3 to 26 months).

CED of cetuximab is a safe and practical adjunctive treatment to surgical debulking in canine patients with intracranial gliomas. Based on this pilot study, CED of bioconjugated cetuximab‐IONPs may be an effective treatment for canine intracranial gliomas. CED infusions can be performed in conscious patients over a 72‐hour duration, which has been shown experimentally to improve volume of diffusion within the target tissue. Ultimately, a larger placebo controlled, blinded clinical trial is necessary and is underway to understand the role of this treatment for canine intracranial gliomas.

SEQUENTIAL MAGNETIC RESONANCE IMAGING OF EXPERIMENTAL INTRACEREBRAL HEMORRHAGE IN DOGS {#jvim12375-sec-0068}
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Intracerebral hemorrhage (ICH) is one of the most lethal stroke types. Neuroimaging techniques, particularly computed tomography and magnetic resonance imaging (MRI), have improved the accuracy of the diagnosis of intracerebral hemorrhage. In human, the MR features of five distinctive stage of ICH have already been reported, but they are not objectively verified in dogs. Therefore, the purpose of this investigation was to document the sequential MR characteristics of canine ICH according to evolving stages.

ICH was induced in 4 healthy laboratory beagle dogs by injecting 500 U of bacterial collagenase from *Clostridium histolyticum*, which was delivered into the parietal lobe over 5 min with a micro infusion pump. T1‐, T2‐ and diffusion‐weighted imaging (DWI), measurement of the apparent diffusion coefficient (ADC), and gradient‐echo (GRE) imaging were performed serially at 6 different time points by using a 3T MR system: before and at 12 h, 2.5, 4.5, 9.5 and 23.5 days after ICH. The MR features of this experiment are summarized in table 1.

Most of the results were different with the previous reports of human. Individual and time variations may vary the MR findings. The present data could be used to differentiate clinical stage of ICH in canine patients.

CEREBELLAR ABIOTROPHY IN A LITTER OF BELGIAN SHEPHERDS {#jvim12375-sec-0070}
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Ataxia was observed in a litter of Belgian Shepherds from phenotypically normal parents. Four puppies (out of 6) of the same litter displayed identical clinical signs. Affected puppies grew well, began to walk normally but, after the 9^th^ week, demonstrated worsening ambulatory difficulties. Three of these puppies presented at the Teaching Hospital for evaluation. General physical examinations were normal; neurologic examinations revealed severe ataxia presumably of cerebellar origin (hypermetric ataxia, intention tremor, delayed proprioception of all limbs, no menace response). All spinal reflexes were normal. The 4^th^ littermate, non‐presented, was the most affected and unable to walk.

Results of complete biochemical and hematological examinations performed in one of the 3 presented puppies were within laboratory reference intervals, except a mild hypomagnesemia. Cerebrospinal Fluid analysis of this dog was normal, with PCR analysis negative for Distemper, Toxoplasma, Neospora and Parvovirus. Magnetic Resonance Imaging of the brain, performed on the 4 affected puppies and a normal female of the same litter, was normal in the non‐affected female, but was compatible with congenital cerebellar abiotrophy in all affected puppies.

The 3 presented puppies were euthanized. Similar histopathological lesions were found, suggestive of cerebellar abiotrophy with loss of Purkinje and granule cells. To the authors 'knowledge, this affection has not been described in this breed.

OPTIMIZATION OF A METHOD FOR ISOLATION, PURIFICATION AND EXPANSION OF ADULT SCHWANN CELLS FROM DORSAL CUTANEOUS CERVICAL NERVES IN DOGS {#jvim12375-sec-0072}
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Cell‐based therapeutic strategies are being developed for neurologic disorders. Schwann cells (SCs) support axonal regeneration and remyelination, and have the advantage of being easily retrievable from the patient, allowing for the transplantation of autologous populations of cells. Important considerations for SC preparation are to reduce contamination by fibroblasts, to obtain a large number of cells in a short period and to avoid detrimental consequences for the patient during harvesting. Here, we reported obtaining nerve biopsies from the dorsal cervical cutaneous region, from which we purified and expanded SCs. We harvested small pieces of dorsal cutaneous cervical nerves from dogs. The predegenerated tissues were cultured in conditions to enhance SC growth while reducing the number of undesired fibroblasts. Cells were immunopurified using magnetic beads and their purity was evaluated by assessing expression of cell surface antigens.

Half a million cells were generated in 10 days from less than 20 mg wet weight of single nerve fascicles. More after the purification processes, the cultures contained more than 80% SCs. However, prolong cell‐doubling time after purification indicated that their SCs ability to proliferate was decreased. We concluded that biopsies of the dorsal cervical cutaneous nerves are a safe and practical culture protocol that yields sufficient autologous SC population for clinical use.

CONGENITAL MYASTHENIA GRAVIS IN A FAMILY OF LABRADOR RETRIEVERS IS CAUSED BY A MUTATION IN THE *COLQ* GENE {#jvim12375-sec-0074}
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Congenital myasthenic syndromes are heterogeneous disorders associated with mutations in proteins residing in the nerve terminal, the synaptic basal lamina, or the post‐synaptic region of the motor endplate resulting in compromise of the safety margin of neuromuscular transmission. Congenital myasthenia gravis (CMG) has been described clinically in a few dog breeds including the Jack Russell Terrier, Smooth Fox Terrier, Long‐haired Dachshund, Old Danish Pointing Dogs, and recently identified in the Labrador Retriever. To date, characterization of CMG at the molecular level has only been performed in the Old Danish Pointing Dogs (mutation in the *CHAT* gene). The purpose of this work is to identify the genetic basis of CMG in a family of Labrador Retrievers.

Causative mutations for human CMG have been identified in 18 genes. To reduce this list of candidate genes, Illumina Canine HD Infinum BeadChips were used to generate genome‐wide SNP profiles for a nuclear family comprised of the sire, dam, 2 affected puppies and 5 unaffected littermates. Genotypes were analyzed for genomic inheritance patterns, with 7 chromosomes having segments consistent with an autosomal recessive mode of inheritance (i.e., heterozygosity in the parents and homozygosity in both affected puppies, with the allele absent or heterozygous in the littermates). The identified regions harbored 3 candidate genes: *CHRND, CHRNG* and *COLQ*. Sequences representing the coding regions of all 3 genes from an affected puppy, the carrier sire and an unrelated Labrador Retriever, revealed a missense mutation in *COLQ* that alters a conserved residue. Evaluation of the mutation in extended family members identified 14 carriers, but it was not found in over 250 unrelated Labrador Retrievers. Our data suggest that a *COLQ* mutation is causative for CMG in Labrador Retrievers, and that proper use of a genetic test should prevent widespread transmission in this popular breed.

DISTINCT ANATOMIC DISTRIBUTION PATTERNS IN CENTRAL NERVOUS SYSTEM LYMPHOMAS CORRELATE WITH BOTH MAGNETIC RESONANCE IMAGING PROFILES AND IMMUNOHISTOLOGICAL TYPES {#jvim12375-sec-0076}
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Canine lymphomas comprise about 83% of all hematopoietic tumors with up to 12% causing intracranial lesions in the central nervous system (CNS). Most CNS lesions are secondary metastases as part of widely disseminated disease in other organs. In contrast, up to 4% have been defined as primary CNS lesions based on the exclusion of extraneural involvement. However there are no studies of any relationship between Magnetic Resonance Imaging (MRI) profiles, immuno‐ and histological phenotypes and any anatomically based patterns in either primary or secondary CNS lymphomas.

In our study of 36 lymphoma cases, which had a rigorous necropsy examination, all were classified as secondary CNS tumors. Immunophenotyping with relevant canine specific cell marker antigens identified 23 B‐cell \[CD79a^+^, CD20^+^, PAX5^+^\] and 12 T‐cell \[CD3^+^, granzyme B^+^\] lymphomas with one suspected non‐B/non‐T cell origin. Of the seven main histologic types following the currently accepted WHO criteria, the diffuse large B‐cell \[n = 15\] and the peripheral T‐cell \[n = 5\] lymphomas were the major ones identified. Each type revealed lesions with a distinct signature of anatomical patterns comprising combinations of parenchymal, meningeal, choroid plexus, subventricular, perivascular and spinal or cranial spinal nerve involvement.

In addition, profiles of each type correlated with MRI changes. Most tumors had disseminated distribution in the spinal cord or/and brain, while the remainder were restricted to either supratentorial \[33%\] or infratentorial \[11%\] sites. The pituitary gland was involved in 68% of the cases irrespective of the immuno‐histological phenotype except for the absence of the large granular T‐cell lymphoma type.

ONCOLOGY {#jvim12375-sec-0078}
========

EVALUATION OF CLIENT PERCEPTIONS REGARDING BARRIERS AND BENEFITS TO VETERINARY ONCOLOGY CLINICAL TRIALS PARTICIPATION {#jvim12375-sec-0079}
---------------------------------------------------------------------------------------------------------------------

**[J.H. Burton]{.ul}^1^, R. Keiffer^2^, R. Livingston^2,3^, C.S. Hardy^1^, R. Page^1^, S.E. Lana^1^**

^1^Colorado State University Flint Animal Cancer Center, Fort Collins, CO^2^A‐Train Marketing Communications, Inc., Fort Collins, CO^3^Advantage Research, Loveland, CO

Clinical trials are used in veterinary medicine to assess the utility and efficacy of new treatment protocols, surgical interventions and diagnostic techniques. While rates of enrollment into clinical trials are widely unknown and likely vary between institutions, there are assumed to be some elements of clinical research which may prevent enrollment of eligible patients into clinical trials. Possible barriers to patient enrollment such as distance from clinic, invasiveness of procedures, and risk of unknown side effects have been postulated as factors that may decrease clinical trial participation but this has not been systematically evaluated in veterinary medicine to date. The purpose of this study was to identify pet owner perceived barriers and benefits to participation in veterinary oncology clinical trials.

Clients of the Flint Animal Cancer Center (FACC) at Colorado State University from 2010 to 2012 were surveyed to evaluate barriers to clinical trial participation, motivators that would increase participation, and other factors that might influence clients\' decision‐making process regarding enrollment. A second population of pet owners that were not clients of the FACC from the Denver metro area was surveyed to evaluate similar criteria.

On‐line surveys were completed by 465 FACC clients and 384 non‐FACC pet owners. The majority of FACC clients did not report distance to the clinic as a barrier to clinical trial participation with 67% willing to drive more than 50 miles. In distinction to those clients already traveling to the FACC, 77% of non‐FACC pet owners in the Denver regions were unwilling to drive greater than 49 miles to participate in a trial. Sixty‐three percent of FACC clients indicated that they were referred to the FACC by their primary care veterinarian and 93% of non‐FACC pet owners reported that their primary care veterinarian was their main resource for cancer treatment recommendations and referral. The reputation of the trials center and referral by the primary care veterinarian were ultimately more influential factors for trials participation than cost of services, risk of side effects, or distance to a clinical trials center for both groups. Both FACC clients and non‐FACC pet owners were more likely to participate in clinical trials if they knew the research would be of benefit to other animals; the possibility that people might benefit from results of a veterinary clinical trial was not as influential.

Veterinary clinical trial recruitment should focus on outreach communication to primary care veterinarians. Availability of trials as well as information regarding benefits and risks should be made readily accessible for easy use by veterinarians. Communication to pet owners should emphasize the benefits of clinical trials specifically to animal health in order to encourage clinical trial participation.

NEW INSIGHTS INTO THE PATHOGENESIS AND TREATMENT OF CANINE THYROID CARCINOMA {#jvim12375-sec-0081}
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**[M. Campos]{.ul}^1^, R. Ducatelle^1^, M. Kool^2^, J. Mol^2^, G. Rutteman^2^, H.S. Kooistra^2^, L. Duchateau^1^, K. Peremans^1^, I. Van de Maele^1^, H. de Rooster^1^, I. Polis^1^, S. Daminet^1^**

^1^Ghent University Faculty of Veterinary Medicine, Merelbeke, Belgium.^2^Utrecht University Faculty of Veterinary Medicine, Utrecht, The Netherlands.

The goals of this research were to investigate the presence of mutations and differences in relative expression of candidate genes, to explore new therapeutic targets and to investigate clinical, pathological and immunohistochemical prognostic markers in canine thyroid cancer.

The medical records of Ghent and Utrecht Universities were reviewed (1986‐2013). Dogs diagnosed with histologically confirmed thyroid neoplasia were included.

Each tumor section (n = 74) was reviewed and scored by a board‐certified pathologist (histologic type,% necrosis,% hemorrhage, nuclear pleomorphism, mitotic index, evidence of vascular or capsular invasion) and immunohistochemistry was performed for calcitonin, Ki‐67, E‐cadherin, cox‐2, VEGF, P‐gp and p53. Differentiation between follicular cell tumors and medullary tumors was based on immunohistochemistry for calcitonin. RNA was isolated from snap‐frozen tumor samples (n = 59) and healthy thyroids (n = 10) and sequencing was performed for mutation hotspots of RAS (K, H and N), PIK3CA, RET and BRAF genes and for the complete coding region of PTEN. Quantitative RT‐PCR was performed for VEGFR1, VEGFR2, EGFR, PIK3CA, PIK3CB, PTEN, PDPK1, Akt1, Akt2, cox‐2 and calcitonin.

All tumors were carcinomas; 54 were follicular thyroid carcinomas (FTC) and 20 were medullary thyroid carcinomas (MTC). In 1 FTC and 1 MTC, 2 missense mutations (G12R and E63K respectively) were found in K‐RAS.

Relative expression of VEGFR1, EGFR, Akt2 and PDPK1 genes was significantly higher in FTC and MTC than in healthy controls.

80% of FTC and all MTC exhibited a very high percentage (76‐100%) of neoplastic cells immunopositive for VEGF. 13% of FTC and 50% of MTC presented cox‐2 expression. 7% of FTC and 70% of MTC presented P‐gp expression. No tumor was immunopositive for p53.

46 dogs (30 FTC and 16 MTC; stage I‐III) underwent thyroidectomy and were included in a survival analysis. Outcome was comparable between FTC and MTC. Inappetence (*P *=* *0.007), histologic vascular invasion (*P *=* *0.027) and surgical vascular invasion (*P *=* *0.005) were associated with shorter disease‐free survival. Histologic vascular invasion (*P = *0.009), large tumor diameter (*P *=* *0.004) and high Ki‐67 labeling index (*P *=* *0.004) were associated with shorter time to metastases.

Relative expression of candidate genes suggests PI3K/Akt pathway activation in both FTC and MTC. VEGF is a potential therapeutic target in both FTC and MTC, while cox‐2 and P‐gp seem to be attractive molecular targets in canine MTC. Intensive monitoring and adjunctive therapy might be indicated when negative prognostic factors are identified.

FRAMELESS STEREOTAXIS IN SMALL ANIMAL BRAIN & SPINE RADIOSURGERY {#jvim12375-sec-0083}
----------------------------------------------------------------

**[L. Malfassi]{.ul}, M. Dolera**

La Cittadina Fondazione Studi e Ricerche Veterinarie, Romanengo (CR), Italy.

Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HSRT) are advanced methods of treatment of tumours, usually performed with an head frame. The purpose of this study was to evaluated the feasibility and efficacy of frameless LINAC based SRS and HSRT in brain and spinal neoplastic disease in dogs and cats. 74 animals (64 dogs, 10 cats) with presumptive (59 cases) or histologically confirmed (15 cases) cancer of nervous system were considered. In 66 cases, RT was curative, in 8 post‐surgical adjuvant. All the patients received a diagnostic high field MRI and a simulation CT. The expansion of GTV to PTV (Planning Treatment Volume) was 3 mm on each directions. For all of them, the feasibility of a frameless SRS or HSRT have been studied using a MonteCarlo statistic algorith and a CMS Monaco 3.0 treatment planning system (TPS) for LINAC 6 MV with beam modulator. To assess the treatment feasibility, treatment simulation have been performed "in air" with the Dosimetric Check software using the Iview portal ASi imager. Each animal was placed in a stereotactic cradle. Positioning verification was performed with cone beam CT. Controls were performed with serial clinical and MRI examination. All patients (37 meningiomas, 22 gliomas, 9 nerve sheath tumours, 6 pituitary tumours, 1 pineal tumour) completed the therapy. The doses delivered ranging from 16 Gy in 1 fraction to 33 Gy in 5 fractions prescribed to the 90% isodose. The RTOG toxicity show 1 G3, 3 G2, 6 G1, 64 G0. The 6 month RECIST efficacy showed 39 partial response, 19 stable disease, 11 complete response, 5 disease progression. The overall response rate was 67%. Either 89% of stable disease patients show a clinical improvement. In 93% of cases a control of disease or a clinical improvement was obtained The toxic effects were quite content. In the short and medium term the efficacy is comparable or superior to that obtainable with other fractionation schedules. SRS and HSRT are safe and effective in the control of nervous system tumours in dogs and cats.

TARGETING GANGLIOSIDES AS TUMORS ANTIGENS FOR CANCER VACCINES {#jvim12375-sec-0085}
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**[R.J. Milner]{.ul}, N. Chimura, M.E. Salute**

University of Florida, College of Veterinary Medicine, Gainesville, FL.

In this research report we provide background and research information on the targeting of gangliosides as tumor antigens and provide results on prospective in‐vivo and in‐vitro studies. Previously we showed that GD3 (disialogangliosides) was found in high concentrations on the surface of canine melanoma cells but at lower concentrations on osteosarcoma cells. When combined with an adjuvant, the vaccine was able to elicit a humoral and cytotoxic cellular immune response in normal dogs. We report on the results from prospective IACUC approved clinical trials in dogs with melanoma.

In a Phase‐1trial (n = 65) dogs were entered and received 3x1‐monthly vaccinations. Accrual included oral, cutaneous, pedal, nodal and anal melanoma. Melanomas were graded; low (n = 13, \< 3MF/10hpf), intermediate (n = 8, 3‐14 MF/10hpf) and high grade (n = 38, \>14 MF/10hpf). Immune responses were monitored using cytokines assays, antibodies, and cytotoxicity assays. No side effects were found using CBC, Chemistry, U/A, and injection site responses, only a single dog showed an allergic reaction (local swelling). Multivariate analysis found anatomic site, histological grade, and univariate analysis found IgG titers, prevaccination NK Assay, tumor stage influenced on survival. Paradoxically, cases with decreased IgG titers had prolonged survival compared to increasing and stable titers. Serum endogenous GD3 concentrations were determined in dogs with melanoma; melanoma cases had higher levels of serum GD3. Case accrual continues in phases‐III of the study, and in an equine melanoma study.

RADICAL CYSTECTOMY AND BILATERAL SUBCUTANEOUS URETEROVESICULAR BYPASS (SUB) PLACEMENT FOR ADVANCED URINARY BLADDER CANCER IN DOGS {#jvim12375-sec-0087}
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**[C. Weisse]{.ul}, A. Berent**

The Animal Medical Center, New York, NY.

Canine urothelial carcinoma remains a disease with poor clinical response to therapy. Initial biological responses are non‐durable and patient death typically occurs within a year or so following diagnosis. Contrary to theoretical advantages, radical surgical resections and rerouting procedure have not provided prolonged survival times; Reported complications may dissuade owners from these procedure. We hypothesized that radical cystectomies with SUB placement would permit more aggressive, wider tumor resections with few associated complications.

Three dogs with extensive bladder TCC, bilateral ureteral obstructions, and incontinence were included. Common comorbidities included severe azotemia (2/3) and previous therapies including previous surgical resection (2/3) and chemotherapy (2/3), among others. Dogs received total cystectomy, bilateral partial ureterectomies, and partial urethrectomy with placement of a bilateral SUB device (Norfolk Vet). There were no major intra‐operative complications encountered and surgical times ranged from 120‐160 minutes. Post‐operative complications included urinary tract infections (3/3) and a kinked urethral catheter requiring an extension added to the subcutaneous port (1/3). All biopsies had tumor cells present at the urethral surgical margin only. Two dogs ultimately died or were euthanized for progressive azotemia (95 days) and a transfusion reaction with no azotemia (48 days). One dog remains alive 244 days post‐operatively. SUB device flushing has confirmed patency in all three dogs. No dogs have been identified to have local tumor recurrence.

Total cystectomy with SUB placement is a potential option for dogs with extensive TCC in order to achieve wide tumor excisions. Large excisions are necessary to achieve complete tumor‐free margins.

RANDOMIZED, BLINDED, PLACEBO‐CONTROLLED TRIAL OF ARTESUNATE WITH DOXORUBICIN FOR B CELL LYMPHOMA OF DOGS {#jvim12375-sec-0089}
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**[J.N. Bryan]{.ul}^1^, D. Tate^1^, S.M. Bechtel^1^, K. Choy^2^, L. Donnelly^1^, K. Fitzpatrick^1^, B.K. Flesner^1^, B. Fowler^1^, B. Gallis^3^, C.J. Henry^1^, C. Herrera^1^, M. Jabbes^2^, K.A. Selting^1^, T. Sasaki^3^**

^1^University of Missouri, Columbia, MO.^2^Washington State University, Pullman, WA.^3^University of Washington, Seattle, WA.

Artemisinin has described anti‐cancer properties. Artemisinin can down‐regulate VEGF, HIF‐1alpha, and survivin in cancer cells, causing apoptotic death. Artesunate, a water‐soluble derivative, has better oral absorption in dogs than artemisinin. The hypothesis was that oral artesunate is tolerable with doxorubicin and results in longer disease‐free interval (DFI) than doxorubicin and placebo in dogs with stage 3a or 4a B‐cell lymphoma.

Twenty‐one qualifying dogs were randomized (blinded) to receive artesunate 20 mg/kg or equivalent placebo. Dogs received study drug alone for 72 hours, then received 30 mg/kg doxorubicin q.3 weeks for three doses with study drug. Thereafter, lymph node measurement, CBC, chemistry profile, and urinalysis were monitored monthly until disease progression. Differences and DFI were compared by Mann‐Whitney and Kaplan‐Meier log‐rank tests. Significance was set at P ≤ 0.05.

Artesunate alone did not cause clinical remission (P = 0.1347). Artesunate induced no biochemical toxicosis. One dog experienced progressive disease following doxorubicin; all others experienced a complete response. Artesunate caused no greater neutropenia or thrombocytopenia following doxorubicin (P = 0.6234 and P = 0.2311). DFI was not different between groups (70d for placebo and 122d for artesunate, P = 0.967). Dogs receiving artesunate had higher nucleated red blood cell counts (median 272nRBC/100WBC artesunate and 9nRBC/100WBC placebo, P = 0.0142). Red cells displayed poikilocytosis and basophilic stippling in artesunate‐treated dogs.

Artesunate did not cause remission as a single agent, nor improved DFI in dogs treated with doxorubicin. 20 mg/kg artesunate caused evidence of heme stress in treated dogs. Artesunate was otherwise well tolerated with doxorubicin. Artesunate cannot be recommended as a therapy for B‐cell lymphoma in dogs.

PRELIMINARY TOXICITY AND EFFICACY OF THE NOVEL ONCOLYTIC VIRUS, VSV‐IFNΒ‐NIS, IN TUMOR‐BEARING DOGS {#jvim12375-sec-0091}
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**[A.K. LeBlanc]{.ul}^1^, S. Naik^2^, G. Galyon^1^, C.J. LeBlanc^1^, S. Frazier^1^, M. Federspiel^2^, K.W. Peng^2^, S.J. Russell^1^**

^1^University of Tennessee College of Veterinary Medicine, Knoxville, TN.^2^Mayo Clinic College of Medicine, Rochester, MN.

Oncolytic virotherapy is an emerging approach to cancer therapy wherein naturally oncolytic viruses mediate tumor destruction and elicit a secondary anti‐tumor immune response. VSV‐IFNβ‐NIS is a novel recombinant oncolytic virus with documented efficacy and safety in preclinical murine models of cancer. Safety studies in normal dogs have determined a safe dose of systemically‐administered virus for clinical studies in tumor‐bearing dogs.

Seven dogs with measurable malignancies were enrolled in an ongoing fixed‐dose clinical trial of either VSV expressing either human Interferon‐β (IFNβ) (n = 3) or canine IFNβ (n = 4) and the sodium iodide symporter (NIS). A variety of malignancies was represented, including B‐ and T‐cell lymphoma, malignant melanoma, and multiple myeloma.

Two of 7 dogs (29%) had a demonstrable partial response to a single IV dose of virus lasting 25 and 35 days, respectively. Both dogs received VSV expressing human IFNβ and had T cell lymphoma. All other treated dogs achieved either stable (n = 1) or progressive (n = 4) disease over the 30 day study period. Clinical toxicities developed within the first 3 days of viral administration in most dogs and included mild to moderate acute, self‐limiting hepatic enzymopathy; fever; and urinary tract infection. Dogs develop neutralizing antibodies within 7‐10 days of viral administration, and do not appear to shed infectious virus in urine or saliva. Infectious virus was isolated from PBMCs of one dog on the day of virus administration only within the first 3 hours following systemic VSV administration

Overall the results demonstrate that measurable responses to oncolytic VSV are observed in dogs with cancer. The starting dose of 10\^10 TCID50 appears well‐tolerated and may allow dose escalation and/or repeated dosing of virus. Additional studies are underway to determine prognostic factors for response to therapy and a wider knowledge of response rates in dogs with hematologic and solid malignancies.

THE ENHANCED TUMORIGENICITY OF CANINE OSTEOSARCOMA CELL LINES IS ASSOCIATED WITH ENHANCED FRIZZLED‐6 EXPRESSION AND SIDE POPULATION CELLS {#jvim12375-sec-0093}
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**[L.C.S. Rodrigues]{.ul}^1^, K.E. Holmes^1^, V. Thompson^1^, M. Newton^2,3^, T.J. Stein^1,3,4^**

^1^Department of Medical Sciences^2^Department of Biostatistics^3^Carbone Comprehensive Cancer Center, and^4^Institute for Clinical & Translational Research; University of Wisconsin‐Madison, Madison, WI.

The Wnt signaling pathway aids in regulating cell proliferation, differentiation, migration, but its aberrant activity has been implicated in tumor development and tumor‐initiating cells. Tumor‐initiating cells have the ability to divide asymmetrically into either additional tumor‐initiating cells or non‐tumorigenic progeny. We performed microarray analysis comparing six canine primary osteosarcoma cell lines and identified 379 genes differentially‐expressed between non‐tumorigenic (n = 3) and tumorigenic (n = 3) cell lines. Among these genes, frizzled‐6 expression was increased to the greatest extent (7.78 fold) in tumorigenic cell lines compared to non‐tumorigenic cell lines. Frizzled‐6 is a co‐receptor for wnt ligands and has been associated inhibition of β‐catenin‐dependent signalling and more aggressive tumors. QPCR and Western blot analyses confirmed the increased expression of frizzled‐6 in the tumorigenic cell lines. Additionally, the tumorigenic cell lines were associated with an increase in percentage of side population cells compared to non‐tumorigenic cell lines (5.89% *versus* 1.58%, respectively). While additional studies are necessary to confirm, it is conceivable the increased expression of frizzdled‐6 expression may be inhibiting the canonical Wnt signaling pathway, and thereby contributing to the formation of tumor‐initiating cells. These newly generated canine primary osteosarcoma cell lines will be beneficial in addressing these important questions.

ACCELERATED RADIATION THERAPY AND ZOLEDRONATE FOR OSTEOSARCOMA BONE PAIN {#jvim12375-sec-0095}
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**[L.D. Garrett]{.ul}, L.E. Selmic, R.L. Kamerer, T.M. Fan**

University of Illinois Department of Veterinary Medicine, Urbana‐Champaign, IL.

The purpose of this investigation was to characterize the clinical effectiveness, bone biologic activities, and biomechanical effects of an accelerated radiation protocol with adjuvant zoledronate for managing canine appendicular osteosarcoma (OS) pain. Prospectively, 54 dogs with OS were treated with ionizing radiation (10 gray x 2, Days 1 and 2), intravenous zoledronate (0.1 mg/kg, Day 2 then every 28 days), and oral analgesics (continuous). Every 28 days, clients completed a pain score assessment form, and objective data including bone biologic effects (urine NTx and DEXA) and biomechanical limb function (computerized gait analysis and videotape assessment) were obtained. Thoracic and limb radiographs were performed initially, at 6 months, and then at regular intervals.

The palliative protocol was well tolerated with no documented unacceptable radiation side effects or toxicity associated with multi‐dose zoledronate administration. Fifty of the fifty‐four dogs have failed, with a median of 201 days (95% CI: 131, 267) to failure. Twenty‐six failed due to local disease, 15 failed due to metastasis, and 9 failed due to other causes. The median time to failure from local disease was 126.5 days (95% CI: 85, 223), while the median time to failure from metastasis was 237 days (95% CI: 119, 298). This difference approached significance (p = 0.055). The median survival time for all dogs was 249 days (95% CI: 168, 309). On univariate analysis, elevation of ALP at diagnosis or tumor location were not found to be prognostic for time to failure or survival. Dogs achieving pain control for greater than 3 months uniformly demonstrated positive changes in bone biologic effects and biomechanical limb function.

Findings from this prospective clinical trial suggest that accelerated radiation, zoledronate, and oral analgesics are well tolerated, provide pain alleviation and exert positive bone biologic and biomechanical effects in dogs with OS.

SMALL ANIMAL INTERNAL MEDICINE {#jvim12375-sec-0097}
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IL‐1β PROTEIN EXPRESSION IS INCREASED IN THE LAMINA PROPRIA OF DOGS WITH FOOD‐RESPONSIVE CHRONIC ENTEROPATHIES AND CORRELATES WITH CLINICAL ACTIVITY INDEX {#jvim12375-sec-0098}
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**S. Schmitz^1^, S. Priestnall^2^, D. Werling^2^, [K. Allenspach]{.ul}^1^**

^1^Department of Veterinary Clinical Sciences and Services^2^Department of Pathology and Pathogen Biology, Royal Veterinary College (RVC), London, UK.

Inflammasomes are intracellular multi‐protein complexes that coordinate the maturation of Interleukin (IL)‐1β and IL‐18 in response to pathogens and metabolic danger signals. Recent research has shown imbalances in the mRNA expression of several signaling proteins of the inflammasome pathway in dogs with chronic enteropathies, however, IL‐1β protein expression has not been assessed so far.

This study investigated IL‐1β expression in the duodenal mucosa of dogs with food‐responsive chronic enteropathies (FRD) before and after treatment and in healthy dogs using immunohistochemistry. Nine dogs with FRD were included in the study and treated with hydrolysed diet for 6 weeks. Biopsies from 5 of these dogs were available after treatment. Clinical scores (CCECAI, Allenspach 2007) were obtained before and after treatment. Duodenal biopsies from 11 healthy Beagles were used as controls. Immunohistochemistry was performed using a polyclonal rabbit anti‐human primary antibody at 1:400 dilution (ab34837, Abcam, Cambridge, UK), followed by the ImmPress^™^ anti‐rabbit peroxidase polymer detection kit as supplied by Vectorlabs. Slides were viewed at x40 magnification using an Olympus BX60 microscope. Cells were counted in 10 randomly selected villous regions and in 10 regions of the sub‐villous lamina propria (LP) and expressed as positive cells per high power field (hpf).

The total count of IL‐1β producing cells was increased in FRD dogs compared to controls, and decreased after treatment with elimination diet (median number of positive cells/hpf in healthy dogs: 9.7, range 1.5‐33.2, FRD before treatment: 17.5, range 1.1‐54.5; FRD after treatment 6.5, range 2.5‐13; Kruskal Wallis p = 0.03, paired t test FRD before *vs* after treatment p = 0.01). Interestingly, this was not reflected by a quantitative change of IL‐1β protein producing cells in the villi (median number of positive cells/hpf in healthy dogs: 9.6, range 1.4‐29.8, FRD before treatment: 10.6, range 0.5‐38; FRD after treatment 3.8, range 1‐6.5; Kruskal Wallis p = 0.06), but was mostly caused by an increase in positive cells in the LP, which did not entirely return to baseline values after treatment (median number of positive cells/hpf in healthy dogs: 1.2, range 0.1‐5.2, FRD before treatment: 6, range 0.6‐20.6; FRD after treatment 2.7, range 1.5‐7.3; Kruskal Wallis p = 0.002, unpaired t test healthy *vs* FRD: p = 0.0002; paired t test FRD before *vs* after treatment p = 0.003). The decrease in IL‐1β positive cell in the LP correlated with the CCECAI (Spearman rank r^2^ = 0.67). In conclusion, this study indicates that IL‐1β protein expression is increased in dogs with FRD compared to healthy dogs, decreases after treatment, and correlates with CCECAI.

EVALUATION OF THE FECAL MICROBIOME IN CATS WITH DIARRHEA {#jvim12375-sec-0100}
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**[J.S. Suchodolski]{.ul}^1^, M.L. Foster^1^, M. Sohail^1^, C. Leuchtenegger^2^, E. Queen^3^, J.M. Steiner^1^, S.L. Marks^4^**

^1^Gastrointestinal Laboratory, Texas A&M University, College Station, TX;^2^IDEXX Reference Laboratories, West Sacramento, CA;^3^VCA Loomis Basin Veterinary Clinic, Loomis, CA;^4^School of Veterinary Medicine, University of California, Davis, CA.

Recent molecular studies have revealed a highly complex bacterial microbiota in the intestine of cats. There is mounting evidence that microbes play an important role in the pathogenesis of acute and chronic gastrointestinal (GI) diseases, as compositional changes of the intestinal bacterial ecosystem have been associated with intestinal inflammation in humans and dogs. The aim of this study was to evaluate the fecal microbiome in cats with diarrhea.

Fecal samples were obtained from healthy cats (n = 21) and cats with diarrhea (n = 48). Diseased cats were further compared based on the duration of their diarrhea: duration \<7 days (n = 19) vs. duration \>7 days (n = 29). The bacterial composition was analyzed by next generation sequencing of the 16S rRNA using the Ion‐Torrent platform (Life Technologies) at a depth of 15,000 sequencing reads per sample. The 16S rRNA gene sequences were also used as input for the bioinformatics software PICRUSt to predict the functional gene content of the microbiome in each disease group. Linear discriminant analysis (LDA) effect size (LEfSe) was performed to identify bacterial groups that were significantly associated with disease and duration. Differences in bacterial groups and predicted gene content between groups were analyzed using Mann‐Whitney tests and Kruskal‐Wallis tests. The resulting P--values were corrected for multiple comparisons using the Benjamini & Hochberg\'s False Discovery Rate (adjusted P \< 0.05).

Significant differences in bacterial groups were detected between healthy cats and cats with diarrhea. Based on LDA, Enterobacteriaceae, *Streptococcus*, Burkholderiales, and *Collinsella* were significantly increased in diarrheic cats, while *Megamonas*, Bacteroidetes, *Helicobacter*, Campylobacterales, and *Roseburia* were significantly increased in healthy cats. Significant differences in abundances of specific bacterial groups were also observed between cats based on duration of diarrhea. Bacteroidetes were significantly decreased in cats with diarrhea \>7 days, while *Lactobacillus* and Erysipelotrichi were significantly decreased in cats with diarrhea \<7 days. The observed changes in bacterial groups were accompanied by significant differences in functional gene contents: metabolism of fatty acids, biosynthesis of glycosphingolipids, metabolism of biotin, metabolism of tryptophan, and ascorbate and aldarate metabolism were all significantly (P \< 0.001) altered in cats with diarrhea.

In conclusion, the above mentioned molecular approach revealed significant differences in the fecal microbiomes between healthy cats and cats with diarrhea. This dysbiosis was accompanied by changes in bacterial functional gene categories. Future studies are warranted to evaluate if these microbial changes correlate with changes in fecal concentrations of microbial metabolites in cats with diarrhea for the identification of potential diagnostic or therapeutic targets.

COMPARISON OF THE FECAL MICROBIOTA OF WILD WOLVES, DOGS FED COMMERCIAL DRY DIETS AND DOGS FED RAW MEAT DIETS {#jvim12375-sec-0103}
------------------------------------------------------------------------------------------------------------

**A. Sturgeon, C.M. Jardine, [J.S. Weese]{.ul}**

University of Guelph, Guelph, ON, Canada.

The domestic dog (*Canis familiaris*) evolved from the grey wolf (*Canis lupus*) approximately 15,000 years ago. There is evidence of divergent evolution in some genes responsible for digestion, but some individuals consider the optimal diet for pet dogs to be an 'evolutionarily appropriate' diet similar to that used by wild wolves, with an emphasis on raw meat feeding. While the genome of wolves and dogs has been compared, the intestinal microbiota of wild wolves and dogs has not been compared, and there has been only limited evaluation of differences in the intestinal microbiota between dogs fed conventional diets and raw meat diets. The objectives of this study were to compare the fecal microbiota of wild wolves, dogs fed conventional dry diets (DC) and dogs fed raw meat diets (DR).

Fecal samples were collected from fifteen pet dogs (10 DC, 5 DR) and ten wild wolves (WW). Next generation sequencing of 16s rRNA gene (V4 region) PCR products was performed and data were analysed using mothur.

1,716,380 sequences passed all quality control filters and were clustered into 215,699 operational taxon units (OTUs). Singletons and doubletons represented 84% of OTUs. Sequences were subsampled to 9,736 reads for comparisons between the dog groups (DC, DR) and the wolves (WW), and to 70,293 reads for comparisons between DC and DR. A two‐dimensional PCoA plot and a phylogenetic tree based on the Jaccard index demonstrated clear differences between wolves and dogs, something that was supported by analysis of molecular variance (AMOVA (\<0.001)). In contrast, there was no difference in microbial population membership or structure between DC and DR groups (*P*=0.41). Species richness was estimated using Catchall at 76552 for dogs and 18686 for wolves.

The most prevalent phyla in the wolf scat were Firmicutes (68.3% of sequences), Proteobacteria (24.9%), Actinobacteria (3.6%), Deinococcus‐Thermus (1.3%), Verrucomicrobia (0.4%), and Fusobacteria (0.4%). Unclassified bacteria represented 0.5% of sequences. Four wolves were almost completely comprised of Firmicutes while Proteobacteria dominated in six. Phylum level distribution was very similar between dogs, with main phyla being Firmicutes (38.3% of sequences), Verrucomicrobia (26.0%), Spirochaetes (2.4%), Fibrobacteres (2.0%), Proteobacteria (1.8%), Bacteroidetes (1.3%), Tenericutes (0.8%), and Fusobacteria (0.4%). In contrast to wolves, unclassified bacteria represented 26.3% of sequences in dog samples.

The fecal microbiota of wolves is highly variable, perhaps as a reflection of the variable and inconsistent diet of wild canids. In contrast, the fecal microbiota of dogs was more conserved, with no difference in population structure between raw‐ and conventionally‐fed dogs. While diet can have an impact on the fecal microbiota of individual dogs, the fecal microbial population membership and structure is relatively conserved amongst the different feeding groups and feeding dogs raw meat does not result in development of a fecal microbiota more akin to wolves.

NUTRITIONAL IMMUNOMODULATION: SPIRULINA FOR IMMUNE & GUT HEALTH IN DOGS {#jvim12375-sec-0105}
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**[A. Reynolds]{.ul}, E. Satyaraj**

Nestle Purina Research, St. Louis, MO.

Spirulina, refers to two species of blue green algae \[*Arthrospira platensis*, and *A*. *maxima*\] consumed by humans as food for centuries. Spirulina has shown immune enhancing properties in animal and human studies attributed to polysaccharides acting via TLR‐dependent processes. However there are no systematic studies evaluating the immunomodulatory effect of Spirulina in dogs. The aim of this study was to evaluate the immunomodulatory effect of diet supplementation with Spirulina in dogs.

The study was conducted in two phases: Pre‐test \[8 wks\] and Test \[40 wks\]. 30 dogs \[mean 2.5 yrs\], were randomized into two groups. In 'Pre‐test' phase both groups were fed a nutritionally complete diet. At the end of 'Pre‐test' phase all dogs received a rabies vaccine, and dogs in 'test group' were switched to nutritionally complete diet supplemented with dried *Arthrospira platensis* \[Spirulina\]. Response to rabies vaccine was evaluated by Rapid Flourescent Focus Inhibition Test (RFFIT). Gut immune response was assessed by measuring fecal IgA. Gut microflora was evaluated by Temporal Temperature Gel Electrophoresis (TTGE) methodology. Repeated measures analysis of variance was used to test for differences between groups and statistical significance considered to be p \<0.05.

Dogs fed diets supplemented with Spirulina demonstrated enhanced immune status by showing significantly higher vaccine response and higher levels of fecal IgA as compared to the control group. Supplementing diets with Spirulina also resulted in significantly increased gut microflora stability in the test group. In conclusion, diets supplemented with Spirulina significantly enhanced immune health and gut health in dogs.

EVALUATION OF A NOVEL TRACHEAL STENT FOR THE TREATMENT OF TRACHEAL COLLAPSE IN DOGS {#jvim12375-sec-0107}
-----------------------------------------------------------------------------------

**[D. Clarke]{.ul}^1^, E. de Madron^2^, R. Presley^3^**

^1^Veterinary Hospital of the University of Pennsylvania, Philadelphia, PA.^2^Alta Vista Animal Hospital, Ottawa, Canada.^3^Upstate Veterinary Specialists, Greenville, SC.

The purpose of this study was to evaluate the safety, efficacy, and satisfaction associated with a novel variable diameter tracheal stent designed specifically for canine anatomy and tracheal collapse.

This was a multicenter retrospective study of 27 consecutive cases of tracheal collapse treated with the stent. Data forms requiring chart review and client interviews were distributed to the veterinarian placing each stent. Information was collected that compared symptoms pre‐ and post‐stenting as well as a number of other parameters relating to the procedure and subsequent clinical course to assess stent performance and ease of use. Symptoms were graded on a visual line scale of 0‐10. Paired t‐tests or sign rank tests were used to determine changes in symptoms following stenting. A two‐sided p‐value of \<0.05 was considered statistically significant.

Responses were obtained from 20 of 27 cases. Data was normally distributed. The mean duration of follow‐up was 3 months (range \>1 to 17 months). There were no procedural complications. Operative mortality was 0%. There were no stent fractures or stent related deaths; symptomatic granulation tissue developed in one case. Statistically significant improvement was seen in cough, respiratory function, quality of life, and exercise tolerance. All veterinarians stated they would use the stent again. 95% of clients would repeat the procedure and 90% expressed satisfaction with the outcome.

Tracheal stenting performed with the novel implant is both safe and subjectively effective in significantly improving clinical symptoms. Veterinarians and clients expressed a positive perception regarding outcomes associated with the stent.

TRACHEAL DIAMETER AND AREA: COMPUTED TOMOGRAPHY VERSUS FLUOROSCOPY FOR STENT SIZING IN 12 DOGS WITH TRACHEAL COLLAPSE {#jvim12375-sec-0109}
---------------------------------------------------------------------------------------------------------------------

**[B.A. Scansen]{.ul}**

Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH.

Implant size for tracheal stenting is conventionally selected by fluoroscopic measurement of maximal dorsoventral tracheal diameter. The aim of this study was to determine if tracheal CT dimensions are comparable to fluoroscopy and also to evaluate the change in tracheal cross sectional area (CSA) between positive pressure ventilation and apnea.

Twelve dogs with tracheal collapse requiring stent implantation were prospectively enrolled. Computed tomography and fluoroscopy were performed during positive pressure and apnea with the endotracheal tube just beyond the larynx. Tracheal diameter was measured in lateral (CT) and dorsoventral (CT and fluoroscopy) planes. Tracheal CSA was calculated from fluoroscopy and directly measured from CT.

The lateral diameter was significantly (P \< 0.0001) wider than the dorsoventral diameter in the cervical (14.0 mm vs. 9.2 mm) and intrathoracic (12.0 mm vs. 8.4 mm) trachea, indicating tracheal shape was more ellipsoid than circular. The cervical and intrathoracic dorsoventral tracheal diameters measured by CT or fluoroscopy were not different (P = 0.69 and P = 0.80, respectively). The CT CSAs of both cervical and intrathoracic trachea were different than fluoroscopy (P \< 0.02). Tracheal CSA was significantly reduced (cervical: 33%, intrathoracic: 36%) during apnea as compared to positive pressure (P \< 0.001).

Tracheal diameter in canine tracheal collapse is greater laterally than dorsoventrally. A stent sized to the dorsoventral fluoroscopy dimension may underestimate the true tracheal CSA, leading to a risk for implant under‐sizing. Tracheal CSA in dogs with tracheal collapse is affected by positive airway pressure, with airway CSA reduced by one‐third during apnea.

EFFECTS OF CYCLOSPORINE AND ASPIRIN ON CANINE PLATELET FUNCTION {#jvim12375-sec-0111}
---------------------------------------------------------------

**[J. Thomason]{.ul}, T. Archer, S. Press, A. Mackin**

Mississippi State University, Starkville, MS.

Immune‐mediated hemolytic anemia (IMHA) has a mortality rate of around 50% in dogs, with pulmonary thromboembolism (PTE) being a common cause of death. Cyclosporine has become a popular agent for the treatment of IMHA; however, recent research in dogs has shown that immunosuppressive dosages of cyclosporine increase platelet reactivity by increasing platelet synthesis of thromboxane A2 (TXA2). Low‐dose aspirin is often given to IMHA patients to inhibit platelet TXA2 synthesis and prevent thromboembolism, and has been shown to decrease mortality rates in dogs with IMHA. Even though aspirin is commonly given concurrently with cyclosporine in dogs with IMHA, it has not been determined if aspirin counteracts cyclosporine‐associated TXA2 synthesis or, alternatively, if cyclosporine counteracts the anti‐platelet effects of aspirin.

In a cross‐over study design, seven healthy young adult dogs were given either low‐dose aspirin (1 mg/kg Q24 hrs PO; Group 1), high‐dose aspirin (10 mg/kg Q12 hrs PO; Group 2), cyclosporine (10 mg/kg Q12 hrs PO; Group 3), or low‐dose aspirin in combination with cyclosporine (Group 4) for 7 days, with a washout period of at least one month between each cross‐over. Platelet function was evaluated prior to (Day 0) and during (Days 3 & 7) therapy using turbidimetric aggregometry (collagen agonist) and PFA‐100^®^ closure time (collagen/epinephrine cartridge). Urinary levels of 11‐dehydro‐thromboxane B2 (11‐dTXB2) were measured via ELISA and normalized to urine creatinine concentration. Aggregometry was performed in quadruplicate, PFA‐100^®^ performed in duplicate, and urinary 11‐dTXB2 levels were analyzed in triplicate, and results were averaged.

Compared to baseline (Day 0), low‐dose aspirin decreased maximal amplitude on aggregometry by 35% & 50% on Days 3 & 7, respectively, and high‐dose aspirin decreased maximal amplitude by 97% on both days. Compared to baseline, cyclosporine increased maximal amplitude by 14% in Day 3, with no change from baseline on Day 7. In Group 4, the maximal amplitude decreased from baseline by 33% and 65% on Days 3 & 7, respectively. By Day 3, PFA‐100^®^ closure times increased by 13%, 150% & 14% from baseline in Groups 1, 2 & 4, respectively; by Day 7, closure times had increased by 72%, 138% & 108%, respectively. By Day 3, urine 11‐dTXB2 levels decreased by 70% & 43% from baseline in Groups 1 & 2, respectively, but increased by 104% in Group 3 and by 24% in Group 4. By Day 7, mean urine 11‐dTXB2 levels decreased by 73%, 11% & 24% from baseline in Groups 1, 2 & 4 respectively, but increased by 168% in Group 3.

Our study confirms that low‐dose aspirin inhibits platelet function, albeit not to the same extent as high‐dose aspirin, and demonstrates that cyclosporine does not significantly alter the effects of low‐dose aspirin on platelet function. Our study also confirms that cyclosporine markedly increases platelet thromboxane A2 synthesis in dogs, and that when cyclosporine and aspirin are given concurrently, cyclosporine appears to significantly reduce the effectiveness of low‐dose aspirin at inhibiting thromboxane synthesis. Further investigation of the effects of concurrent cyclosporine and low‐dose aspirin on platelet reactivity is warranted in patients at risk of PTE.

THE EFFECT OF ORAL ACID SUPPRESSANTS ON INTRAGASTRIC pH IN CATS {#jvim12375-sec-0113}
---------------------------------------------------------------

**Parkinson^1^, [K. Tolbert]{.ul}^1^, K. Messenger^2^, A. Odunayo^1^, M. Brand^1^, A. Reed^1^, E. Peters^3^, G. Davidson^2^, M.G. Papich^2^**

^1^Univ of Tennessee College of Veterinary Medicine, Knoxville, TN.^2^North Carolina State University, Raleigh, NC.^3^GlaxoSmithKline, Research Triangle Park, NC.

Gastrointestinal erosion and ulceration are common sequelae to gastric and non‐gastric disorders in cats. Acid‐suppressing drugs are a mainstay of therapy. Generic tablets containing omeprazole (OT) or famotidine are widely available and can be modified by cat owners to treat their pets. Fractionated enteric‐coated OT and famotidine are among the most widely prescribed acid suppressants. However, once broken, the effect of enteric‐coated OT in raising gastric pH may be significantly compromised. Moreover, studies have not been undertaken in cats to determine the efficacy of these different acid suppressants. The objectives of these studies were to compare the pharmacodynamics and pharmacokinetics of oral omeprazole formulations and famotidine in cats.

Healthy adult cats (n=6) were used in a randomized, 4‐way crossover design. All cats received 0.88‐1.26 mg/kg q12 hr of fractionated enteric‐coated omeprazole tablets, omeprazole paste (Gastrogard^®^ diluted in cod liver oil at 10 mg/ml), famotidine tablets, and twice daily placebo (lactose capsules). Intragastric pH monitoring (Bravo system^®^) was used to continuously record intragastric pH for four days (treatment days 4‐7) followed by a 10‐day washout period. Plasma omeprazole concentrations at steady state (day 7) were determined by HPLC with ultraviolet detection. Mean percentage time (MPT) the intragastric pH was ≥ 3 and 4 were compared among groups using ANOVA. Tukey‐Kramer test was used to determine which groups were different (α = 0.05).

MPT that intragastric pH was ≥ 3 and 4 were significantly (p \< 0.0001) greater for cats receiving omeprazole tablet and paste compared to famotidine and placebo. Famotidine was significantly different from placebo. Mean ± SD percentage of time the intragastric pH was ≥ 3 was 68.4 ±35.0% for fractionated enteric OT, 73.9 ± 23.2% for omeprazole paste, 42.8 ±18.6% for famotidine, and 16.0 ± 14.2% for placebo. Mean ± sd plasma omeprazole concentrations on day 7 (steady state) were similar in cats receiving tablet compared to paste and in a range associated with acid suppression in other studies.

These results demonstrate that both omeprazole formulations provide superior acid suppression in cats compared to famotidine or placebo. Fractionated enteric‐coated OT is an effective acid suppressant despite disruption of the enteric coating.

THE DETECTION OF CALCIFYING NANOPARTICLES IN THE URINE OF CATS AND DOGS AND THEIR ROLE IN CALCIUM OXALATE UROLITHIASIS {#jvim12375-sec-0115}
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**[J.L. Westropp]{.ul}^1^, M.M. Mellema^1^, Y. Queau^2^, R. Shiraki^1^, V. Biourge^2^**

School of Veterinary Medicine, University of California Davis^1^ andRoyal Canin Research Center, Aimargues, France.^2^

Calcium oxalate (CaOx) is the most common urolith submitted to our laboratory from dogs and cats. The pathophysiology of CaOx stone formation is poorly understood, but research in humans suggests a link between calcifying nanoparticles (CNP) and urolithiasis. CNPs are comprised of crystallized minerals and organic molecules; the aggregation and size of urinary CNPs is altered in lithogenic patients and reports suggest CNPs are associated with the presence of Randall\'s plaques Furthermore, studies in humans have reported alterations in CNP size, morphology, and aggregation that helped inhibit calculus formation in patients receiving potassium citrate, a therapeutic drug for CaOx management.

To date, there are no studies evaluating CNPs in small animals. We developed a flow cytometry protocol to detect CNPs generated *in vitro*. We confirmed these particles were indeed apatite based on transmission electron microscopy studies. Nanoparticle tracking analysis was used to evaluate canine urine samples and a uniform population of particles was detected in the exact primary CNP size range (80‐90 nm). Furthermore, these particles auto‐fluoresced similar to particles that contain significant amounts of mineral. Fluorescent marker studies are ongoing.

We have developed a protocol to detect CNPs in the urine of dogs. Future studies in animals will determine if 1) we are able to detect urine/plasma CNPs in cats and 2) if differences in CNP quantity, size and stability are predictive of lithogenic propensity. CNP assays may also provide a tool for identifying urinary determinants of crystal aggregation and subsequent stone formation in small animals.

METABOLIC AND GENETIC DETERMINANTS OF CALCIUM OXALATE UROLITHIASIS IN DOGS {#jvim12375-sec-0117}
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**[E. Furrow]{.ul}, J.P. Lulich, J.R. Mickelson, P.J. Armstrong, K.M. Minor, E.E. Patterson**

University of Minnesota College of Veterinary Medicine, St. Paul, MN.

The objectives of this study were to: 1) determine if hypercalciuria underlies calcium oxalate (CaOx) urolith risk in the Miniature Schnauzer (MS), Bichon Frise (BF), and Shih Tzu (ST) and 2) identify a susceptibility gene for CaOx urolithiasis in the MS using a genome‐wide association study (GWAS).

MS, BF, and ST cases had a history of CaOx uroliths. Controls were ≥8 yo and had no uroliths on screening radiographs. Serum iCa^2+^ and fasting urinary calcium‐to‐creatinine ratios (UCa/Cr) and oxalate‐to‐creatinine ratios (UOx/Cr) were measured. MS dogs were genotyped on whole‐genome SNP chips for the GWAS; next‐generation sequencing was used to identify variants within the disease‐associated locus.

The metabolic analyses included 45 MS (23 cases, 22 controls), 28 BF (14 cases, 14 controls), and 13 ST (7 cases, 6 controls). MS and BF cases had higher serum iCa^2+^ than breed‐matched controls (p\<0.05), though all values were within the reference interval. For all breeds, cases had higher UCa/Cr than breed‐matched controls (p\<0.005). UOx/Cr were not different.

The GWAS included 104 MS (62 cases, 42 controls). A strong association signal was present on chromosome 37 (praw = 8x10^‐6^, pgenome = 0.01). Sequence results were evaluated for 18 genes in the critical region. No coding variants were identified, but putative regulatory variants were found in a solute carrier gene, *Slc39a10*. Knockdown of the gene in a *Drosophila* CaOx model increases stone volume.

Hypercalciuria is associated with CaOx urolithiasis in 3 canine breeds. Genetic mapping in MS dogs identified *Slc39a10* as a potential CaOx susceptibility gene.

A TWO‐YEAR‐LONG PROSPECTIVE, RANDOMIZED, DOUBLE‐MASKED STUDY OF NUTRITION ON THE RECURRENCE OF CALCIUM OXALATE UROLITHIASIS IN STONE FORMING CATS {#jvim12375-sec-0119}
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**[J. Lulich]{.ul}^1^, J. Kruger^2^, J. MacLeay^3^, J. Merrills^2^, I. Paetau‐Robinson^3^, J. Brejda^4^, S. Steck^2^, S. Davidson^1^, C. Osborne^1^**

^1^University of Minnesota, St. Paul, MN.^2^Michigan State University, E. Lansing, MI.^3^Hills Pet Nutrition, Inc., Topeka, KS.^4^Alpha Statistical Consulting, Inc. Lincoln, NE.

Calcium oxalate (CaOx) uroliths account for approximately 40% of feline stone submissions to the Minnesota Urolith Center. To date, no study has followed affected cats long term to determine the rate of recurrence, confounding factors and the effect of dietary intervention.

This study was a 2‐ year‐long, randomized, double‐masked and controlled study examining 2 foods for management of CaOx urolithiasis. Compared to the Control (Ctl) food the Test food contained greater amounts of anti‐oxidants and n3 fatty acids, and less Ca and Mg with a target urine pH of 6.2‐6.4. The Ctl food was designed to be similar to popular grocery brands and had a target urine pH of 6.6‐6.8. Foods were otherwise similar and met minimum AAFCO requirements for adult cats. Protocols were ACUC approved. Cats with a recent history of confirmed CaOx uroliths were recruited. Owners were given the choice of food form (wet, dry or combined) and then cats were randomized onto Test or Ctl foods. Cats were evaluated at 4 month intervals by physical examination, abdominal radiography, urinalyses and serum chemistries. 24‐hour urine collections for chemistry and relative super saturation (RSS) calculation were conducted at 4 and 24 months or at detection of stone recurrence. Data were analyzed as a factorial combination of food, hypercalcemia (HCa), and recurrence.

36 cats were recruited and 33 (17 Test, 16 Ctl) completed the study and were included in the analysis. Of these, 12/33 (36%) had intermittent HCa. HCa was detected in 4/17 (23.5%) Test food and 8/16 (50%) Ctl food fed cats. Stone recurrence was observed in11/33 (33%) of cats overall, and was detected in 5/17 (29.4%) Test food and in 6/16 (37.5%) Ctl food fed cats. RSS CaOx and urine\[Ca\] were significantly higher in cats with stone recurrence, cats fed the control food, and cats with HCa. A significant (p\<0.05) interaction between HCa and food was observed for RSS CaOx. The least square means for RSS CaOx were 5.10 (SEM 0.77) for nonHCa/Test, 4.56 (1.3) for HCa/Test, 4.15 (0.96) for nonHCa/Ctl, and 12.88 (0.96) HCa/Ctl. Urine pH was significantly different between foods, but not between cats with HCa or stone recurrence.

These results suggest that recurrence of CaOx uroliths and HCa may be lower in cats fed the nutrition of the Test food. This affect may be due to a mitigating effect of the Test food on urine calcium. The recurrence of CaOx urolithiasis is multifactorial and occult HCa may play a larger role in this disease than is typically recognized.

COMPARISON OF RELATIVE SUPER SATURATION FOR CALCIUM OXALATE TO A NEW METHOD TO DETERMINE THE PROPENSITY OF URINE TO PRECIPITATE CALCIUM OXALATE, THE CALCIUM OXALATE RISK INDEX {#jvim12375-sec-0121}
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**[J.M. MacLeay]{.ul}^1^, H.M. Schiefelbein^1^, I.V. Raymond‐ Loher^2^, S. J Davidson^1^**

^1^Hill\'s Pet Nutrition, Inc., Topeka, KS.^2^Aerotek Inc., Raleigh, NC.

Calcium oxalate (CaOx) urolithiasis accounts for approximately 40% of all cases of urolithiasis in cats and 33% of cats are likely to reform a stone within 2 yrs. Therefore, there is a need to develop a test that can routinely predict the risk that a cat may form or reform a stone to provide feedback that a given intervention is lowering risk. Relative super saturation (RSS) is regarded as the best method to evaluate urine. However, the test is not commercially available to the veterinary community, is labor intensive and costly. The RSS software is dated and of the 2 versions available; one, SuperSat^®^, is proprietary and yields results different than the other, Equil 2. Further, RSS uses a limited number of metabolites which cannot fully evaluate the complex system of urine where many promoters and inhibitors interact. As such, RSS is limited in its ability to predict the propensity of urine to form a stone. The human Bonn Risk Index uses whole urine and better reflects the risk of stone formation. The Calcium Oxalate Risk Index (CORI) is similar in principle to the human Bonn Risk Index. Briefly, whole urine is titrated with a sodium oxalate solution until precipitation occurs. The CORI value is determined by dividing the urine \[Ca^2+^\] by the resultant amount of oxalate added at the point of precipitation.

A panel of 12 healthy adult cats was used in this ACUC approved study. Cats were individually housed with group exercise and social interaction in spacious rooms with natural light. Cats were fed a series of 22 different foods with varying nutritional profiles, each for 28 days, over the course of 2 years. Foods varied in form (dry or wet) and were always fed to maintain body weight. A 24‐hr urine collection was performed on day 28. Equil 2 software was used to calculate RSS from urine concentrations of NH4^+^, Ca^+2^, Cl^‐^, Citrate, creatinine, Mg^+2^, oxalate, PO4^‐3^, K^+^, Na^+^, SO4^‐2^ and urine pH. SAS^™^ version 9.2 was used for all analysis. CaOx RSS and the CORI results were moderately correlated (r = 0.54, p \< 0.0001). RSS CaOx was weakly correlated to both urine pH (r = ‐0.19, p\<0.05) and RSS Struvite (r=‐0.11, p = 0.05). CORI, however, was not correlated with either urine pH (r= 0.03, p = 0.62) or RSS Struvite (r= ‐0.05, p = 0.35). Nutritional profiles of foods and individual urinary constituents were analyzed to determine drivers for RSS CaOx and CORI. The CORI test provides several advantages over RSS CaOx; It has the potential to be a commercially available test, it can provide veterinarians and pet owners with rapid feedback concerning the success of an intervention and, most importantly, through the use of whole urine, it takes into account the entire milieu of urinary constituents that affect the propensity to form a calcium oxalate stone. Further work will continue to determine the impact of nutrition and previous stone status on CORI.

PREVALENCE OF VARIANT ALLELES ASSOCIATED WITH PROTEIN‐LOSING NEPHROPATHY IN AIREDALE TERRIERS {#jvim12375-sec-0123}
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**[M.P. Littman]{.ul}, M.G. Raducha, P.S. Henthorn**

University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.

Previously we showed that protein‐losing nephropathy (PLN) in Soft‐coated Wheaten Terriers (SCWT) is associated with variant alleles in linkage dysequilibrium in two adjacent genes, NPHS1 and KIRREL2, which encode slit diaphragm proteins nephrin and filtrin/Neph3, respectively. In SCWT, homozygous positive (2‐2) dogs are at highest risk, heterozygous (1‐2) dogs are at intermediate risk, and homozygous negative (1‐1) dogs are at lowest risk for the development of PLN. Among 753 dogs of 114 non‐SCWT breeds, only 3 dogs (2 Airedales and 1 Bloodhound) showed these alleles, including one homozygous positive Airedale terrier that died with PLN.

Cheek swab, blood, or semen samples of DNA were tested from 221 Airedale Terriers (median age 4 yrs) from widely dispersed regions of the United States and Canada to study the prevalence of the alleles in the Airedale breed and determine if breeders can safely remove carrier dogs in one generation. Results of haplotype frequencies are tabulated below. Genetic counseling would be of benefit to the Airedale community to help breeders avoid producing homozygous positive dogs.

1‐1 (%)1‐2 (%)2‐2 (%)Variant Allele Frequency (%)Female AiredalesIntact, n=8942.550.5732Neutered, n=4659414.521Total, n=1354847.528Male AiredalesIntact, n=554942930Neutered, n=2065251023Male Unknown, n=875258.513Total, n=8355.53627Unknown Sex, n=3336733TOTAL, n=2215143628YEAR OF BIRTH \*includes one semen sample from a deceased dog born in 19901995‐2001, n=1656446222002‐2005, n=4965292202006‐2009, n=51494911262010‐2011, n=5735545382012‐2013, n=3954411126Unknown\*, n=9563328

PLACEBO‐CONTROLLED ASSESSMENT OF ALLOGENEIC MESENCHYMAL STEM CELLS FOR THE TREATMENT OF FELINE CHRONIC KIDNEY DISEASE {#jvim12375-sec-0125}
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**[J.M. Quimby]{.ul}, T.L. Webb, E. Randall, A. Marolf, A. Valdes‐Martinez, S.W. Dow**

Center for Immune and Regenerative Medicine, Department of Clinical Sciences, Colorado State University, Fort Collins, CO.

Feline chronic kidney disease (CKD) is characterized by chronic tubulointerstitial nephritis, and inflammation contributes to the progression of renal fibrosis. Mesenchymal stem cells (MSC) have demonstrated anti‐inflammatory and anti‐fibrotic effects in rodent CKD models. The purpose of this study was to evaluate the use of allogeneic MSC for treatment of feline CKD.

MSC were isolated from the cryopreserved adipose of SPF research cats and culture‐expanded. CKD cats were enrolled in a placebo‐controlled, blinded one‐way crossover clinical study. Four CKD cats were randomized to receive 2 x 10^6^ MSC/kg intravenously at 2, 4, and 6 weeks. Three CKD cats were randomized to receive placebo, with one cat crossing over to the MSC treatment group. CBC, chemistry, and urinalysis were performed at weeks 0,2,4,6, and 8. Glomerular filtration (GFR) via nuclear scintigraphy and UPC were performed at zero and 8 weeks.

Five cats received 3 doses of fresh, culture‐expanded MSC without adverse effects. No significant change in serum creatinine, GFR, UPC, or PCV was seen in cats treated with MSC. Individual changes in GFR were 12%, 8%, 8%, ‐13%, and ‐67% in treated cats compared to 16%, 36%, and 0% control cats. Discordant creatinine and GFR results were observed: the treated cat that experienced the greatest decrease in creatinine also experienced the greatest decline in GFR.

Administration of MSC expanded from cryopreserved adipose were not associated with side effects, however no discernable immediate improvement in renal function was appreciated. Long‐term follow up is necessary to determine effect on progression of disease.

URINARY CLUSTERIN AND SERUM INOSINE: BIOMARKERS FOR EARLY IDENTIFICATION OF ACUTE KIDNEY INJURY IN DOGS {#jvim12375-sec-0127}
-------------------------------------------------------------------------------------------------------

**[C.A. Palm]{.ul}^1^, G. Segev^2^, L.D. Cowgill^1^, J. Quinn^3^, Z. Mirolee^3^, M. Yerramilli^3^, E. Obare^3^, M. Yeramelli^3^**

^1^UC Davis School of Veterinary Medicine, Davis, CA.^2^Koret School of Veterinary Medicine, Hebrew University, Jerusalem, Israel.^3^IDEXX Laboratories, Inc., Westbrook, ME.

A key factor in the high mortality rate associated with acute kidney injury (AKI) in dogs is the lack of sensitive tests to identify early stages of disease. Novel urinary and serum biomarkers may identify AKI earlier than traditional markers. Urinary clusterin (uClusterin), an apolipoprotein, is overexpressed during renal tubular injury and elevations have correlated with damage severity. Serum inosine (sInosine) is a metabolite of adenosine deamination produced by proximal tubular cells in health. The purpose of this study was to evaluate the utility of uClusterin and sInosine for early AKI diagnosis in a canine model of AKI.

AKI was induced in 5 dogs by gentamicin administration (10 mg/kg SC q 8 hours). Serum creatinine (sCreatinine), sInosine and uClusterin were measured twice daily during AKI induction.

AKI (defined as a 50% increase of sCreatinine above baseline) occurred on median day 16 (range, 14‐19 days). Comparatively, median uClusterin increased above the cut‐off value (190 ng/mL) on median day 4 (range, 4‐7 days; *P* = 0.008). Baseline median uClusterin was 67 ng/mL (range, 10‐71 ng/mL) and peaked at 2866 ng/mL (range, 1233‐5115 ng/mL) on median day 17, a 43‐fold increase above baseline. Median baseline sInosine was 241 ug/dL (range, 134‐427 ug/dL) and declined steeply following gentamicin administration in all dogs (decreased by 1.7‐fold on median day 2, and by 6‐fold on median day 3).

In a gentamicin induced canine model of AKI, changes in uClusterin and sInosine preceded changes in sCreatinine; these novel markers show promise for early AKI detection in dogs.

EFFICACY OF CANINE ANTI‐NERVE GROWTH FACTOR ANTIBODY FOR THE ALLEVIATION OF DEGENERATIVE JOINT DISEASE‐ASSOCIATED PAIN IN DOGS {#jvim12375-sec-0129}
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**[B.D.X. Lascelles]{.ul}^1,2^, M. Freire^1^, D. Knazovicky^1^, B. Case^1^, K. Jiamachello^1^, D. Gearing^3^**

^1^Comparative Pain Research Laboratory^2^Center for Comparative Medicine and Translational Research; NCSU CVM, Raleigh, NC.^3^Nexvet, Melbourne, Australia.

There is a critical need for proven drugs other than non‐steroidal anti‐inflammatory drugs for treatment of degenerative joint disease (DJD) pain in dogs. Antibodies against Nerve Growth Factor (NGF) are analgesic in rodent models and in humans with DJD. This pilot study aimed to evaluate the efficacy of a novel caninised anti‐NGF antibody (NV‐01) for the treatment of DJD pain in dogs.

In a placebo‐controlled, masked clinical study, 26 dogs with DJD were randomized to NV‐01 (200 mcg/kg IV) or placebo. In addition to objective accelerometry measures, owners completed clinical metrology instruments (Client‐Specific Outcome Measures \[CSOM\] and Canine Brief Pain Inventory \[CBPI\]) on days 0, 14 and 28. CSOM and CBPI subscales (pain severity \[PS\] and pain interference \[PI\]) were evaluated within and between groups. Recognized success/failure criteria were applied and success compared between groups.

CBPI PS and PI scores significantly improved in the NV‐01 group (PS: Day 0‐14, *P* = .010 and Day 0‐28, *P* = .025; PI: Day 0‐14, *P* = .006 and Day 0‐28, *P* = .032) but not in the placebo group. CSOM scores showed similar patterns with a significant difference between groups at day 14 and day 28 (*P* = .011 and *P* = .033, respectively), and significantly more successes at day 28 (*P* = .037). No side effects were noted. Objectively measured activity significantly increased in the NV‐01 group (*P* = .045), not in the placebo group (*P* = .811).

These pilot data demonstrate a positive analgesic effect of anti‐NGF antibody in dogs suffering from chronic pain. The magnitude of the effect was identical to that expected with an NSAID.

EQUINE {#jvim12375-sec-0131}
======

CHOROIDAL VASCULITIS DURING EXPERIMENTAL AND NATURALLY OCCURRING EHV‐1 INFECTION IN HORSES {#jvim12375-sec-0133}
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Faculty or College of Veterinary Medicine at ^1^Ludwig‐Maximilians University, Munich, Germany.^2^Michigan State University, East Lansing, MI.^3^North Carolina State University, Raleigh, NC.^4^Oklahoma State University, Stillwater, OK.^5^Colorado State University, Fort Collins, CO.

Equid Herpesvirus type 1 (EHV‐1) is the cause of respiratory disease, Equid Herpesvirus‐associated Myelopathy (EHM), late term abortions and chorioretinopathies in horses. Following infection of the respiratory tract, a cell‐associated viremia is often established leading to virus dissemination and endothelial cell (EC) infection of the spinal cord vasculature, the pregnant uterus or the eye. Previously, we showed focal or multifocal shotgun lesions in 50% or more of experimentally infected horses between 5 -- 7 weeks post infection (p.i.). Based on this data our hypothesis was that eye lesions are caused by EC infection resulting in vasculitis similar to what occurs for EHM and that the incidence of EHM correlates with the incidence of ocular lesions.

To test this hypothesis, 8 mixed breed horses, aged 18 -- 22 years, were infected with EHV‐1 (strain OH03), and euthanized on day 14 p.i.. Clinical signs of neurological disease were evaluated between days 1‐14 post infection and eyes were collected post euthanasia. In addition, eyes of a yearling horse that developed acute neurologic signs following experimental infection with EHV‐1 strain Ab4 and one eye of a middle‐aged gelding that developed neurological signs during the 2011 EHV Ogden, UT outbreak were collected. Neurological gait abnormalities of all horses were scored on a scale of 0 (no abnormalities) to 5 (severe abnormalities). In addition, ocular tissues were processed at Colorado State University and histological sections were collected and stained with H&E and immunohistochemistry (IHC) was performed using an anti‐EHV‐1 antibody. Eye lesions were described and degrees of choroiditis/vasculitis (CV) were scored according to severity and frequency on a scale from 0 (no lesions) to 3 (abundant lesions). A correlation coefficient between eye lesion score and clinical neurological gait abnormalities was determined and differences were considered significant at a p‐value \< 0.05.

The yearling horse and the Ogden‐horse had severe, frequent CV (≥grade 2). In the OH03‐study, 6/8 horses were graded ≥1; 4/8 horses were graded ≥2 and 2/8 horses were graded 3. IHC was positive in the yearling and in the Ogden‐horse, while horses in the OH03experiment were positive only on occasion. A clinical neurological gait abnormality score during the OH03 infection experiment did not correlate well with eye lesions (R^2^= 0.65).

In summary, while the pathogenesis of ocular EHV‐1 and EHM might be similar and viral antigen was detected in some of the infected horses, no significant correlation between neurological disease and ocular disease was detected. This lack of viral antigen in the eyes of some of the horses exhibiting neurological disease may have been due to the time point of euthanasia and a lack of sensitivity of the assays selected.

A NOVEL STRATEGY TO BOOST ANTIBODY PRODUCTION TO EQUINE HERPESVIRUS TYPE 1 (EHV‐1) IN FOALS {#jvim12375-sec-0134}
-------------------------------------------------------------------------------------------

**[G.A. Perkins]{.ul}, L.B. Goodman, S. Babasyan, H. Freer, A. Keggan, A. Glaser, S. Torsteinsdóttir, V. Svansson, S. Björnsdóttir, B.A. Wagner**

Cornell University, College of Veterinary Medicine, Ithaca, NY.

Foals respond poorly to existing vaccines that are optimized for the adult immune system. Our hypothesis is that foals can be protected against EHV‐1 infection by a vaccination that activates T‐cell independent B‐cell memory and antibody production.

Iceland is considered free of EHV‐1. Pregnant Icelandic mares (n=15) were imported to an isolation facility in February 2012. The foals born in that spring suckled colostrum that was free of maternal EHV‐1 antibodies. Foals either received equine IgE at birth by nasogastric tube and 2 days later recombinant EHV‐1 glycoprotein C (gC) antigen intramuscularly (IM); or received EHV‐1 gC antigen IM on day 2 of life; or received no treatment. At 7‐months of age, foals were weaned and infected with EHV‐1. Physical examinations were done daily. EHV‐1 viral DNA and anti‐EHV‐1 gC antibodies were measured in the blood and nasal secretions before and after infection. Repeated measures ANOVA with Dunn\'s post‐tests to compare individual groups were done.

All foals developed a fever. At 36‐h post‐infection (p.i.), the vaccinated foals had a significantly lower temperature (p\<0.05). EHV‐1 DNA was detected by qPCR in nasal swabs for the first week p.i. and there was no significant difference between groups. Serum and nasal anti‐EHV‐1 gC antibodies increased by day 8 p.i. and this was significantly higher in magnitude in the vaccinated foals (p\<0.001).

Our novel equine neonatal vaccination provided some protection against EHV‐1 clinical disease and prepared the foal\'s adaptive immune system to respond more rapidly and robustly to EHV‐1 infection.

COMPARISON OF INNATE IMMUNE RESPONSES IN EQUINE RESPIRATORY EPITHELIAL CELLS TO MODIFIED‐LIVE EQUINE INFLUENZA VACCINE AND RELATED WILD‐TYPE INFLUENZA VIRUS {#jvim12375-sec-0136}
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**H.L. Pecoraro^1^, D. Koch^1^, G. Soboll Hussey^2^, L. Bentsen^1^, [G.A. Landolt]{.ul}^1^**

^1^Colorado State University, Fort Collins, CO.^2^Michigan State University, East Lansing, MI.

Equine influenza virus (EIV) is an important equine respiratory pathogen that continues to cause disease and suffering in horses. In order to design effective EIV control strategies, it is crucial to understand how to invoke long‐term protective immunity. While systemic IgG titers have long been used as a correlate for protection from EIV infection, systemic antibody titers are not always accurate predictors of clinical protection. The cold‐adapted, modified‐live virus (MLV) vaccine (FluAvert I.N.^®^, Merck Animal Health) induces only weak systemic antibody responses. Despite this, the vaccine has been shown to provide clinical protection for up to 12 months after a single vaccine administration. This suggests that mechanisms other than humoral responses are critically important in EIV immunity. While the adaptive immunity to EIV has been well characterized, there is a lack of information regarding the innate immune responses occurring at the airway epithelium during EIV infection.

The objective of this study was to compare the innate immune responses of primary equine respiratory epithelial cell (EREC) cultures following infection with either the MLV vaccine strain or a closely related wild‐type EIV strain (A/Equine/Kentucky/1/91; Eq/KY). It was our hypothesis that infection with the MLV vaccine strain elicits similar innate immune responses in equine airway cells as seen following infection with the wild‐type virus.

Equine airway epithelial cells were collected from the upper and lower respiratory tract of respiratory healthy animals and the cells were grown at the air‐fluid interface until fully differentiated. Subsequently, cell cultures were inoculated with a multiplicity of infection (MOI) of 10 with either the MLV strain or Eq/KY and incubated at either 30°C or 37°C. Twelve, 24, and 48 hrs after inoculation, cell culture subnatants and cells were collected and assayed for protein and mRNA expression of IFN‐α, IFN‐γ, IL‐4, IL‐6, IL‐10, IL‐17, TNF‐α, and TLR3 & 9.

Inoculation of ERECs with either virus resulted in up‐regulation of both mRNA and cytokine expression. The degree of up‐regulation was dependent on virus strain, site of cell collection (upper versus lower respiratory tract) and incubation temperature used. Moreover, the expression levels appeared to be associated with viral replication efficiency.

These results highlight the fact that immunity to influenza virus is multifaceted and involves several arms of the host\'s immune response. Whether innate, antibody‐independent mechanisms play a role in the observed clinical protection following intranasal vaccination with the MLV vaccine remains to be investigated.

INFECTIOUS DISEASES OF WORKING EQUIDS: HAVEMEYER WORKSHOP REPORT {#jvim12375-sec-0138}
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**[N. Aklilu]{.ul}^1^, A. Stringer^1^, D.P. Lunn^2^**

^1^SPANA, Ethiopia^2^NCSU, Raleigh, NC.

A workshop was held in November, 2013 in Addis Ababa, Ethiopia, attended by 35 international delegates representing academia, NGO\'s, the OIE and government agencies. The goal was to identify ways to reduce the burden of infectious diseases in working equids worldwide.

The size of the working equid population is estimated to be 75% of the 112 million world domestic equid population, although this may significantly under‐represent the true population. The majority of working equids live in low‐income countries, and have a major socio‐economic role in the livelihoods of equid‐owning households. Information on the occurrence of infectious diseases in these populations is often incomplete, but there is clear evidence of wide regional distribution of high morbidity and mortality including African Horse Sickness, EIA, influenza, rabies, tetanus, glanders (Burkholderia mallei), epizootic lymphangitis, piroplasmosis, trypanosomiasis, and GI nematodes. Importantly, participatory surveys of equid owners, and observations by field workers identify both respiratory and neurological disease syndromes as having high impact and warranting further investigation. Strategies for equine disease surveillance where there is under‐reporting and lack of diagnostic infrastructure were contrasted with other species in the same regions, and systematic data gathering coupled with new indicators of disease impact will be needed for progress. Understanding equine ecology was repeatedly demonstrated to be critical to disease control, and promoting control measures that can be adopted by owners through education is a top priority.

The workshop made two key sets of recommendations. The first was in regards impediments to progress, and these fell into three categories: Technical --principally lack of data including equid numbers and movement, and disease surveillance,; Behavioral -- principally lack of equine management education and understanding of socio‐economic impact,; Institutional: principally lack of equine status affecting all aspects of resource allocation. The second set of recommendations were in regards how to address disease challenges in three categories. For the first set of diseases the major technical barriers to progress are limited, and what is needed is advocacy to address behavioral and institutional barriers to progress; examples include African Horse Sickness and tetanus. For the second set of diseases significant knowledge and technical barriers remain in addition to behavioral and institutional barriers, and research is urgently needed to address these gaps; examples include epizootic lymphangitis, and blood borne parasites. The third set of diseases represent essentially syndromic diagnoses, and these require thorough investigation and renewed surveillance to determine diagnosis with a high degree of certainty. The need and opportunity to reduce infectious disease in working equids is enormous, and increased global and local advocacy based on equine welfare and the socio‐economic impacts will be essential for success. Global networks of investigators can play a critical role in building regional capacity towards addressing these needs.

DIFFERENTIATION OF EQUINE MESENCHYMAL STROMAL CELLS INTO NEURAL CELLS: POTENTIAL FOR CLINICAL APPLICATIONS {#jvim12375-sec-0142}
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**[C. Cruz Villagrán]{.ul}, L. Amelse, N. Neilsen, M. Dhar**

University of Tennessee College of Veterinary Medicine, Knoxville, TN.

Peripheral nerve injuries are a cause of poor performance in horses. These injuries are difficult to manage and treatment mostly relies on physical therapy and anti‐inflammatories; however, the long term effects are time and personnel consuming. Our objective was to test the ability of equine mesenchymal stromal cells (MSCs) to differentiate into neuronal lineage, with subsequent trans‐differentiation into Schwann cells for nerve regeneration.

Bone marrow‐derived MSCs were obtained from 3 young and 4 adult horses. Following demonstration of stemness, cells were neuronally induced in tissue culture plates and microscopically assessed at 3, 6, 12, 24 and 48 h. Results showed that PRIMARIA^™^ plates supported proliferation and differentiation. Survival was improved by high number of cells. Morphological changes were observed as early as 3 hours; at 12 h approximately 60% of the cells were neuron‐like. Morphology was similar in all horses, but proliferation was variable. Protein concentration was influenced by cell number and method of protein extraction. Expression of neuronal progenitor proteins, vimentin, β3 tubulin and GFAP, was detected by immunoblot analysis; nestin was not evident.

Results demonstrate that equine MSCs can differentiate into neuronal lineage. Future work is aimed to trans‐differentiate these cells into Schwann cells and to evaluate survival when co‐cultured with peripheral nerve. Expression of Schwann cell specific markers, S100B, Krox20 and CD104, will be tested.

DISPOSITION OF LEVETIRACETAM IN SERUM AND CEREBROSPINAL FLUID AFTER SINGLE DOSE ORAL ADMINISTRATION OF PIONEER AND GENERIC LEVETIRACETAM IN HEALTHY ADULT HORSES {#jvim12375-sec-0143}
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**[A.J. Stewart]{.ul}, J. Costello, D.M. Boothe, S.H. Duran, A.D. Ramos, F.B. Cesar**

College of Veterinary Medicine, Auburn University, Auburn, AL.

Levetiracetam (LEV) is a novel anti‐epileptic drug. Our purpose was to determine the disposition of pioneer (Keppra^™^) verses generic levetiracetam in horses.

Six healthy adult horses were administered 30 mg/kg PO of pioneer and generic LEV in a cross‐over design. Serum and CSF samples were collected over 48 hrs for pioneer (n = 5), and over 12 hrs (n = 3) and 24 hrs (n = 3) for the generic formulation. LEV concentrations were analyzed via an immunoassay. Pharmacokinetic parameters were compared using paired t‐tests, with P ≤ 0.05 considered statistically significant.

For the pioneer and generic formulations the maximum concentrations (Cmax) were similar within serum (22.1 ± 8.5, 20.1 ± 5.6 μg/mL, P = 0.4), and CSF (10.9 ± 1.4, \>11.0 ±3.0 μg/mL, P = 1.0), respectively. The predicted area under the curve to infinity (AUC) for the pioneer and generic formulations in serum were similar (364 ± 56.6, 338 ± 21.0 hr\*μg/mL, P = 0.72). AUC after pioneer administration in CSF =333.6 ± 41.5 hr\*μg/mL.

After administration of the pioneer, the Cmax, AUC, half‐life (T1/2), mean residence time (MRT), apparent volume of distribution (Vz_F) and apparent clearance (Cl) were all greater in the CSF than serum. Tmax was greater for CSF than serum.

ParameterPioneerGenericSerumCSFP valueSerumAUC (hr\*μg/mL)364 ± 56.6334 ± 41.50.03338 ± 21Cmax (μg/mL)22.1 ± 8.510.9 ± 1.40.03\>20.1 ± 5.6Tmax (hr)9 ± 6.720.4 ± 5.40.009\>9.0 ± 5.2T½ (hr)6.6 ± 1.29.4 ± 1.50.0027.3 ± 0.9 (n=3)MRT (hr)15.5 ± 3.427.0 ± 3.60.0000213.0 ± 1.5 (n=3)Oral Clearance (mL/hr/kg)85.6 ± 1.7100 ± 12.70.000990.3 ± 5.7 (n=3)VD_F (mL/kg)835 ± 1491,364 ± 1980.0003524 ± 105 (n=4)

Generic and pioneer LEV formulations were considered similar, which may make the use of levetiracetam affordable for the treatment of seizures in horses.

FACTORS AFFECTING SUSCEPTIBILITY OF YOUNG ADULT HORSES TO EQUINE HERPESVIRUS MYELOENCEPHALOPATHY {#jvim12375-sec-0145}
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**[L.K. Maxwell]{.ul}, T.C. Holbrook, L.L. Gilliam, G.B. Rezabek, R. Eberle, T.A. Snider, D. McFarlane, C.A. Jamieson, T. Kievitsbosch, D.H. Black**

Oklahoma State University, Stillwater, OK.

Previous work has demonstrated that aged horses are more susceptible to equine herpesvirus myeloencephalopathy (EHM) than are young horses. However, the basis for this difference has not yet been established. The objective of this work was to determine whether immunocompetency or blood brain barrier permeability contributes to susceptibility of horses to EHM. We hypothesized that: 1) decreased cell‐mediated immunity, induced by cyclosporine administration, increases susceptibility to EHM, 2) increased permeability of the blood brain barrier (BBB), induced by mannitol and lipopolysaccharide administration, enhances susceptibility to EHM. Sixteen horses, mares and geldings aged 2‐5 years, were randomized to 4 treatment groups: cyclosporine only, BBB disruption, cyclosporine plus BBB disruption, and untreated controls. Horses were inoculated intranasally with equine herpesvirus type 1 (EHV‐1), and horses were assessed until 15 days post‐inoculation (DPI). Significant findings were: 1) body temperature and nasal shedding of EHV‐1 did not differ between groups (*P *\>* *0.05), 2) viremia was higher at 5 DPI in the cyclosporine treated horses as compared with control horses (*P *\<* *0.05), 3) viral load in neurological tissues was higher in the horses in which only cyclosporine was administered (*P *\<* *0.05), 4) maximum ataxia and clinical scores were higher in the horses in which only cyclosporine was administered, but not significantly so (*P *=* *0.18, 0.11, respectively). This study suggested that immunocompetency was more important to the pathogenesis of EHM in young horses than was BBB integrity. Further studies are warranted to determine which aspects of the immune response affected by cyclosporine administration are necessary for development of EHM.

INVESTIGATION OF A UNIQUE *THEILERIA EQUI* VARIANT IN THE UNITED STATES {#jvim12375-sec-0147}
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**[L.N. Wise]{.ul}, L. Kappmeyer, D. Knowles**

Washington State University, Pullman WA.

Recent routine horse surveillance in South Texas, which included serologic testing for *Theileria equi,* identified a stray horse with inconsistent results on the commercially available competitive ELISA. Additional testing was performed and while the horse was negative for *T. equi* by cELISA, PCR and IFA, a transfer of blood into a naïve, splenectomized horse resulted in a "*T. equi* ‐like" infection. 18s rRNA analysis confirmed an infection with a theilerial species with almost 100% identity to isolates from horses and zebras in South Africa. Further analysis showed this isolate to be quite different from *T. equi* isolates identified to date in North America.

Genome sequencing was completed with Illumina^®^ technology and paired bac end reads in a *de novo* assembly. Numerous differences were noted between this isolate and the genome of domestic *T. equi* but of particular interest is the *ema* (equi merozoite antigen) gene family. This gene family encodes immunodominant surface merozoite EMA proteins and antibodies against these proteins are utilized in diagnostic testing. This *T. equi* variant possesses divergent *ema* family members, which explains the inconsistent test results.

The implications of identifying this variant within the U.S. are extensive and the genetic work described here will serve as the basis for further research on this parasite.

A SYSTEMATIC REVIEW AND META‐ANLYSIS OF THE EFFICACY OF FRUSEMIDE FOR EXERCISE INDUCED PULMONARY HEMORRHAGE IN THOROUGHBRED RACEHORSES {#jvim12375-sec-0149}
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**[S.L. Sullivan]{.ul}, G.A. Anderson, T. Whittem, P.S. Morley^\#^, K.W. Hinchcliff**

University of Melbourne, Victoria, Australia;^\#^College of Veterinary Medicine, Colorado State University, Fort Collins, Colorado, USA.

Frusemide is the most commonly used medication for EIPH, however, critical evaluation of the strength of evidence for efficacy of frusemide is lacking. The objective of this systematic review and meta‐analysis was to evaluate the use of frusemide to reduce the severity or frequency of detection of EIPH in Thoroughbred racehorses. Studies were identified via searches of electronic databases, relevant texts and reference lists of published articles. Studies were not restricted by language, date or publication status. Search terms included exercise induced pulmonary h\*morrhage, f\*semide, treatment, horse, equine. Included studies were randomised and non randomised trials, prospective observational studies and experimental studies. Data extraction was performed by one author. Three authors independently assessed each study using the GRADE recommendations of rating quality of evidence. Meta‐analysis of studies was performed with a random effects model to determine if frusemide reduced the frequency of detection of EIPH (yes or no) or if frusemide reduced the severity of EIPH by at least 1 tracheobronchoscopic grade. Stata 13.1 and MedCalc 12.7.7 performed the analyses.

Seventeen studies fulfilled the inclusion criteria, and 7 provided data for meta‐analysis. Frusemide reduced the risk of detecting EIPH by 17% (pooled data from 7 studies, n = 4948, RR 0.83, 95% CI 0.72 -- 0.95, p = 0.006). Significant heterogeneity existed (I^2^ = 66.5%, p = 0.0065), which was not explained by a meta‐regression that included if the study design was paired or unpaired (p = 0.14). When data from the two RCTs (paired designs) were used in the meta‐analysis, the RR of horses treated with frusemide was 0.68 (95% CI 0.58 -- 0.79, p \< 0.001). The proportion of horses diagnosed with EIPH after a control treatment that had a reduction of at least 1 EIPH grade after frusemide was 0.69 (95% CI 0.61 -- 0.76).

Meta‐analysis of methodologically robust trials, using a validated outcome measure in horses from the target population, indicates frusemide reduces the frequency and severity of EIPH when compared to untreated horses or horses administered a saline placebo.

EMERGING OUTBREAKS OF CORONAVIRUS IN ADULT HORSES {#jvim12375-sec-0151}
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**[N. Pusterla]{.ul}^1^, S. Mapes^1^, C. Wademan^1^, A. White^1^, R.L. Ball^2^, K. Sapp^2^, P. Burns^3^, C. Ormond^4^, K. Butterworth^5^, J. Bartol^6^, R. Steere^7^, T. Hanyi^8^, L. Scott^9^, J. Higgins^10^, L. Fielding^10^, S. McIntosh^10^, J. Higgins^10^, K.G. Magdesian^1^**

^1^School of Veterinary Medicine, University of California, Davis, CA.^2^Bracken Equine Clinic, San Antonio, TX.^3^Elkhorn Veterinary Clinic, Elkhorn, WI.^4^Oak Hill Veterinary Services, Orinda, CA.^5^SRH Veterinary Services, Ipswich, MA.^6^New England Equine Medical & Surgical Center, Dover, NH.^7^Artaurus Veterinary Clinic, Petaluma, CA.^8^South Jersey Equine Associates, Vineland, NJ.^9^Idaho Equine Hospital, Nampa, ID.^10^Loomis Basin Equine Medical Center, Penryn, CA.

Equine coronavirus (ECoV) has been identified by electron microscopy, culture and more recently by PCR in feces of foals with and without enteric disease. Two recent studies reported on the isolation of ECoV from the feces of 2‐ to 4‐year‐old horses with pyrogenic and enteric disease living in stables of a racetrack in Japan. However, little is known about ECoV, especially with regard to molecular diagnostics of field samples and the clinical significance of ECoV PCR positive fecal results. The purpose of this study was to describe clinical, hematological and fecal PCR results from 268 horses involved in outbreaks associated with ECoV.

The outbreaks happened at eight separate boarding facilities between November 2011 and November 2013 in the States of CA, TX, WI, MA, NJ and ID. The population of horses per stable ranged from 8 to 70 horses. Following the molecular detection of ECoV in the feces from the initial index cases, the remaining herdmates were closely observed for the development of clinical signs. Fecal samples were collected from sick and healthy horses for the PCR detection of ECoV. Clinical pathology from sick horses was evaluated when available.

All eight outbreaks involved primarily adult horses. Eighty horses developed clinical signs with 3 to 16 sick horses per outbreak. The main clinical signs reported were anorexia (79), lethargy (70) and fever (65). Diarrhea and colic were observed in 17 and 8 horses, respectively. Further, 4 horses develop acute onset of encephalopathy. Clinical signs generally resolved within 1‐4 days with supportive care. Nine horses from six different outbreaks were euthanized or died due to rapid progression of clinical signs. The cause of death in these horses was attributed to endotoxemic shock, septicemia or metabolic derangements. Blood work was available from 22 horses and common hematological abnormalities were neutropenia and/or lymphopenia. Feces were available for ECoV testing by PCR from 61 and 173 sick and healthy horses, respectively. The overall agreement between clinical status and PCR detection of ECoV was 90%. In conclusion, ECoV infection in adult horses is generally associated with self‐limiting clinical and hematological abnormalities, although compromised intestinal barrier can lead to severe secondary complications and death. ECoV infection is supported by a positive fecal PCR result.

SAFETY AND IMMUNOREACTIVITY OF A XENOGENEIC DNA PLASMID VACCINE EXPRESSING HUMAN TYROSINASE IN TUMOR‐BEARING HORSES {#jvim12375-sec-0153}
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**L.M. Lembcke^2^, J.T. Blackford^2^, D.A. Grosenbaugh^3^, T. Leard^3^, S.A. Kania^2^, D.J. Trent^2^, K. Prater^2^, J. Biggerstaff^2^, A. Odoi^2^, [J.C. Phillips]{.ul}^1^**

^1^Lincoln Memorial University College of Veterinary Medicine, Harrogate, TN.^2^University of Tennessee, Knoxville, TN.^3^Merial Ltd., Athens, GA.

The purpose of this study was to evaluate the safety and immunologic activity of the pING‐HuTyr plasmid (Oncept^™^) in horses diagnosed with melanoma. This vaccine has been previously reported to be effective for treating melanoma in dogs. To accomplish our goal we proposed a study wherein the vaccine was used in gradually escalating doses in horses that had been diagnosed with melanoma while temporally measuring immunologic response in these treated patients. The protocol involved treating a total of 15 horses with a series of 4‐biweekly injections along with a 6‐month booster. Biologic samples were collected during the protocol to measure antibody and in vitro cellular reactivity to human tyrosinase, cellular reactivity to equine tyrosinase, and finally to characterize tumor infiltrating lymphocyte populations.

No adverse reactions have been seen in any of the vaccinated patients. Objective responses were seen in 13 of 15 treated horses. Positive humoral responses were seen in all treated horses. Cellular reactivity was noted in 13 of 15 treated patients. Characterization of tumor infiltrating lymphocyte populations identified a statistically significant increase in CD8 +  lymphocytes along with a decrease in CD4 + /Foxp3 +  regulatory T cells following vaccination. Increasing plasmid dose did not appear to be associated with an increase in either clinical activity or immunologic reactivity. This xenogenic vaccine appears to be safe and well tolerated in tumor bearing horses and appears to result in both clinical activity and a measureable immune response in treated patients.

RETROSPECTIVE ANALYSIS OF *STREPTOCOCCUS EQUI* SUBSP *EQUI* INFECTIONS IN 108 HORSES IN THE FIELD (2005‐2012) {#jvim12375-sec-0155}
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**L. Duffee, [A.G. Boyle]{.ul}, R.C. Boston**

University of Pennsylvania, New Bolton Center, Kennett Square, PA.

Strangles is a contagious acute infection of the upper respiratory tract caused by *Streptococcus equi* in horses. This multiple outbreak retrospective study examined the risk factors for strangles diagnosis and prevalence of disease complications.

Computerized field service medical records were examined from 2005‐2012. Strangles cases (108) were selected based on the presence of classic clinical signs (fever, lymphadenopathy, and nasal discharge) in a confirmed outbreak, positive *S. equi* PCR or aerobic culture. Control cases (207) were selected by the presence of a fever (\>101.5 °F) over the same time period. Data collection included signalment, clinical signs, diagnostic testing, therapies, disease complications, and hematological values and were analyzed through descriptive and regression statistical methods.

Significant risk factors *(p *\<* *0.05) for strangles diagnosis included: 2‐7 years old (OR 3.22); presence of fever, nasal discharge and external abscess (OR 96.3); hyperfibrinogenemia \>700 mg/dL (OR 2.71); and anemia (OR 3.08). A leukocytosis \>12,000 cells/uL trended towards strangles diagnosis (OR 2.32). Contrary to previous reports, fever and external abscesses were found in 60% and 22% of cases, respectively. 30% (14/46) of horses tested prior to treatment were PCR positive in the absence of external clinical signs.

Our study showed a higher prevalence of purpura hemorrhagica (9% \[OR 2.55\]), prolonged (\>29 days) *S. equi* PCR positive horses (8/44 \[18%\]), but a lower prevalence of metastatic disease (4%) than previously reported.

Fever and abscessation may be insufficient in disease screening when used alone. Clinical signs and disease complication rates observed over multiple outbreaks differed from previously published data.

ADRENAL STEROIDS, STEROID PRECURSORS AND NEUROSTEROIDS IN HOSPITALIZED NEWBORN FOALS {#jvim12375-sec-0157}
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**[K.A. Dembek]{.ul}^1^, S.D. Hurcombe^1^, N.M. Slovis^2^, B.S. Barr^3^, R.E. Toribio^1^**

^1^The Ohio State University, College of Veterinary Medicine; Columbus, OH, USA;^2^Hagyard Equine Medical Institute, Lexington, KY, USA;^3^Rood and Riddle Equine Hospital, Lexington, KY, USA.

Hypothalamic‐pituitary‐adrenal axis (HPAA) dysfunction (relative adrenal insufficiency; RAI), has been associated with sepsis and mortality in newborn foals. However, comprehensive information on the adrenal cortex response to sepsis in sick foals is limited. Most studies have been focused on cortisol, while other essential adrenocortical steroids, steroid precursors, and neurosteroids have been overlooked. We hypothesized that adrenal steroids, precursors, and neurosteroids concentrations will be higher in sick compared to healthy foals on admission, and will remain unchanged or increase over the next 24 h of hospitalization in septic foals. Hormone and delta steroid concentrations will be associated with severity of disease and mortality rate.

Blood samples were collected on admission (time 0) and at 24 h (time 1) from 15 septic, 15 sick non‐septic (SNS) and 4 healthy foals of ≤5 days of age. Blood concentrations of corticoliberin (CRH), adrenocorticotropin (ACTH), cortisol, aldosterone, pregnenolone, progesterone, 17α‐OH‐progesterone, androstenedione, dehydroepiandrosterone (DHEA), and allopregnanolone were determined by immunoassays. The delta steroid was defined as steroid concentration difference between time 0 and 1.

Cortisol, ACTH and CRH concentrations were higher in septic than in healthy foals on time 0 (p \< 0.05). Septic foals had higher CRH, ACTH, cortisol, aldosterone, pregnenolone, progesterone, 17 α‐OH‐progesterone, androstenedione, DHEA concentrations compared to SNS and healthy foals at time 1 (p \< 0.05). There was no difference in allopregnenolone concentrations between foals groups. Delta pregnenolone and 17α‐OH‐progesterone were lower and delta CRH was higher in septic compared to healthy foals. Healthy foals had lower aldosterone, 17 α‐OH‐progesterone and pregnenolone at time 1 compared to time 0. Non‐surviving hospitalized foals had higher CRH, ACTH, cortisol and progesterone concentrations compared to surviving foals at time 1. Aldosterone, pregnenolone and 17α‐OH‐progesterone concentrations were higher in foals that died at both time points (p \< 0.05).

The adrenocortical response to sepsis in foals is characterized by persistently increased steroid concentrations over the first 24 h of hospitalization and foals for which steroids increase after admission are more likely to die. Aldosterone, pregnenolone, progesterone, and 17α‐OH‐progesterone concentrations are good predictors of non‐survival at admission and 24 h post‐admission in hospitalized foals.

AICAR ADMINISTRATION AFFECTS GLUCOSE METABOLISM BY UPREGULATING THE NOVEL GLUCOSE TRANSPORTER, GLUT8, IN EQUINE SKELETAL MUSCLE {#jvim12375-sec-0159}
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**M.A. de Laat^1^, M.A. Robinson^2^, K.J. Gruntmeier^1^, S. DiNello^2^, L.R. Soma^2^, [V.A. Lacombe]{.ul}^1^**

^1^Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK.^2^New Bolton Center, University of Pennsylvania, Kennett Square, PA.

Equine metabolic syndrome is characterized by obesity and insulin resistance (IR). Currently, there is no effective pharmacologic treatment for this insidious disease. Glucose uptake is mediated by a family of glucose transporters (GLUT), which is regulated by insulin‐dependent and ‐independent pathways, including the 5‐AMP‐activated protein kinase (AMPK). Importantly, downregulation of AMPK has been implicated in the pathogenesis of IR. In addition, the activation of AMPK, by 5‐aminoimidazole‐4‐carboxamide‐1‐D‐ribofuranoside (AICAR), stimulates glucose uptake in both healthy and diabetic humans. However, whether AICAR promotes glucose uptake in horses has not been established.

Blood samples and gluteal muscle biopsies were obtained from 5 healthy horses before and up to 6 hours following an intravenous AICAR infusion. Protein expression of major GLUTs (‐1, ‐4, ‐8) and (total and phosphorylated) AMPK was quantified by Western blotting in skeletal muscle. Treatment with AICAR resulted in a decrease (P = 0.001) in blood glucose concentration and an increase (P \< 0.001) in insulin concentration. There was a trend toward an increase in skeletal muscle protein content of total and phosphorylated AMPK (P = 0.05 and 0.06, respectively) by 1 hour after treatment. While GLUT4 and ‐1 protein expression remained unchanged, GLUT8 was increased (P \< 0.05) following AICAR treatment.

Upregulation of GLUT8 protein expression by AICAR suggests that this novel GLUT isoform plays an important role in equine muscle glucose transport. In addition, these data suggest that AMPK activation enhances pancreatic insulin secretion. Collectively, these data suggest that AICAR acutely promotes muscle glucose uptake in the horse and thus its therapeutic potential for managing IR requires investigation.

FACTORS ASSOCIATED WITH VARIATION IN THE EQUINE INCRETIN RESPONSE IN A COHORT OF MORGAN HORSES AND WELSH PONIES {#jvim12375-sec-0161}
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Hyperinsulinemia and insulin resistance are components of equine metabolic syndrome (EMS), a condition associated with predisposition for laminitis development. Incretins play a key role in glucose homeostasis and the insulin secretory response. The incretin hormone glucagon‐like peptide‐1 (GLP‐1) produced by endocrine cells of the gastrointestinal tract promotes the release of insulin in response to oral sugar administration. GLP‐1 has a short half‐life due to rapid inactivation by the enzyme dipeptidyl peptidase‐4 (DPP‐4). Our objective was to investigate variability in the equine incretin response and identify factors associated with incretin response variation. Glucose (GLU), insulin (INS), total GLP‐1 (GLP1tot), and active GLP‐1 (GLP1a) concentrations were determined in 56 Morgan horses and 56 Welsh Ponies from 7 farms at baseline and 15, 30, 60, 75, 90, and 120 minutes following an oral sugar challenge. Baseline DPP‐4 activity, prior laminitis status, obesity status (body condition score BCS ≥7), age, breed, sex, and diet measurements were also collected. For repeated measures, a quadratic random regression analysis was performed with respect to time. Independent variables included time, age, breed, sex, obesity/laminitis status, baseline DPP‐4 activity, and diet variables. Farm was also included as a random effect. Significant "rise‐fall" curves were detected for the population\'s mean GLU, INS, GLP1a, and GLP1tot with peak estimates occurring at 90, 75, 60, and 60 minutes, respectively. Significant positive correlations were detected for INS/GLU, GLP1a/GLP1tot, INS/GLP1a, and INS/GLP1tot. Baseline GLU correlated positively with obesity status. Horses with a higher daily caloric intake had a lower GLU rate of change over time. Baseline INS was positively correlated with age, DPP‐4 activity, obesity and prior laminitis status and was significantly lower in geldings. Baseline GLP1tot was negatively correlated with total daily caloric intake, but was associated with a significantly higher GLP1tot response over time. In contrast, starch was positively correlated with GLP1tot at baseline, but resulted in a significantly lower rate of change in GLP1tot over time. Baseline GLP1tot was significantly higher in stallions than geldings. However, the GLP1a and GLP1tot had a significantly lower rate of change over time in stallions. Baseline measurements of DPP‐4 activity were significantly greater in Welsh ponies and negatively correlated with age. Findings indicate horses exhibit changes in blood GLP‐1, insulin, and glucose concentrations following an oral sugar challenge characteristic of an incretin response. Significant factors associated with variation in this response include DPP‐4 activity, obesity status, gender and dietary factors.
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*Salmonella enterica* is one of the most common causes of healthcare associated infections in veterinary teaching hospitals, the most common cause for equine hospital closure, and among the top three agents associated with illness in veterinary personnel. When *Salmonella* spreads among patients, environmental contamination is predictably present -- whether as cause or effect. Additionally, subclinical infections and shedding in the absence of disease is much more common than clinical infections. Unfortunately, current detection methods generally lack in sensitivity; prolonging time to detection. Consequently risk recognition and the ability to rapidly identify high‐risk patients and environmental contamination are critical to effective management of populations and their environments. The objectives of this project were to determine factors associated with shedding of *S. enterica* among the general inpatient population and associated environmental contamination during times of endemic disease -- for the purpose of endemic and epidemic disease prevention.

From March 2002 through December 2012, fecal cultures were performed on all large animal inpatients (n = 11,061) on admission and twice weekly during hospitalization; and environmental cultures were performed monthly at predetermined locations throughout the facility (n = 5337). Variables characterizing the patient population and hospital were collected retrospectively from the electronic medical records database. Multivariable logistic regression was used to evaluate associations between factors of interest and both patient shedding of *S. enterica* and associated environmental contamination.

During the study period, approximately 5.9% (n = 648) of patients were fecal culture positive for *S. enterica* -- the majority being bovine (73.5%; 476/648) and equine (22%; 143/648). In addition, approximately 7.9% (n = 423) of environmental samples were culture‐positive using standard culture techniques. In general, indicators of severe disease were related to patient shedding; and environmental samples collected in the Livestock Hospital, from floor surfaces, and during times of high caseload were more likely to be positive.

Factors identified in this study not only permit refinement of existing infection control programs, but provide a better understanding of the epidemiology of *Salmonella* in veterinary hospitals -- allowing for evidence based preventive measures to be implemented in infection control programs on a daily basis.

FOOD ANIMAL {#jvim12375-sec-0165}
===========
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Bovine Lymphotropic Herpes Virus (BLHV), is a member the *Herpesviridae* family, subfamily *Gammaherpesvirinae*. I report the detection of BLHV DNA in specimens submitted to OADDL during 2006‐2013. The role of BLHV in clinical cases of cattle has not been reported before.

The partial BLHV herpesvirus DNA (about 250 base pairs) was detected using pan herpes virus PCR and confirmed by sequence analysis of conserved polymerase gene of herpes viruses using BLASTn analysis.

A total of 130 bovine specimens (fresh tissues collected at necropsy included Brain (n = 27); Lung (n = 25); and other specimens, (n = 18) and ante mortem specimens included nasal swabs (n = 20), eye swabs (n = 6), and un‐clotted blood (n = 21) were tested. A small number of other ante‐mortem specimens (CSF) were also tested.

Out of 130 specimens collected from respiratory and nervous tissues, 47 were positive and 83 were negative. The clinical signs and histopathology lesions were sudden death, high fever, neurologic disease, and respiratory disease. A small number of normal nasal swabs were also tested from clinically normal cattle.

BLHV DNA was detected by PCR in specimens from eight states in the USA. Based on the findings, I conclude that BLHV was detected by pan herpes virus PCR in respiratory and nervous tissue specimens. Based on detection in sterile tissues, such as brain and presence of severe lesions on histopathology, such as perivascular cuffing, I conclude that BLHV is a pathogen of cattle with sudden death and nervous disease. However, the role of BLHV in upper respiratory tract disease based on nasal swabs is still unclear because the BLHV was detected in the nasal cavity of clinically normal cattle also. However, the role of BLHV in cases of bovine pneumonia was supported by presence of severe chronic lesions, such as interstitial pneumonia.

TRANSIT TIME IN THE LARGE INTESTINE OF COWS WITH CECAL DILATATION/DISLOCATION IN COMPARISON WITH HEALTHY CONTROL COWS AND COWS WITH LEFT DISPLACEMENT OF THE ABOMASUM {#jvim12375-sec-0168}
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Cecal dilatation/dislocation (CDD) is a common and economically important abdominal disorder affecting mainly dairy cattle. Whereas the clinical aspects of CDD are well described, the pathogenesis of the disease remains poorly understood. Therefore, adequate recommendations for prevention of the disease remain elusive. A primary motility disturbance in the spiral colon has been suspected to be the cause of CDD. Therefore, a minimally invasive technique was developed to assess the transit time in the bovine large intestine in cows with CDD in comparison with healthy cows and cows with left‐sided displacement of the abomasum (LDA) to localize the primary motility disorder leading to CDD.

Cows with spontaneous CDD (n = 15), healthy control cows (n = 14) and cows with LDA (n = 18) were included in the study. Five water‐tight polioxometalate capsules, each containing a build‐in temperature sensor and electronic transmitters, were introduced in the lumen of the ileum, cecum, proximal loop of the ascending colon (PLAC) and two locations in the spiral colon to measure the transit time, defined as the time between implantation of the devices in the intestine and an abrupt drop in the measured temperature indicating excretion of the transmitters. The transit times from the different intestinal segments were compared among groups by use of the Kruskal‐Wallis test.

The technique for transit time assessment in the bovine intestine was safe and reliable. A high variability in the transit times was observed in all intestinal segments and in all groups. In addition, the output sequence was irregular, i.e. the capsules implanted in the most distal intestinal segments were not always excreted first. Statistical analysis revealed a significant difference (p = 0.009) in the transit time from the distal location in the spiral colon among the 3 groups of cows, with the longest median time in cows with CDD. A particularly marked variability and prolonged transit times were observed in the calculated transit time between the PLAC and the proximal location in the spiral colon in cows with CDD, but the difference among groups was not significant (p \> 0.05).

The high degree of variability observed will preclude the routine use of transit time measurements for indirect assessment of intestinal motility in cattle. However, the results obtained in the present study allow confirming the role of a motility disorder in the bovine colon in the pathogenesis of CDD.

THE EFFECTS OF MULTIVALENT MODIFIED‐LIVE VIRAL VACCINES ON REPRODUCTIVE PERFORMANCE {#jvim12375-sec-0170}
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Prebreeding vaccination should provide fetal and abortive protection against reproductive pathogens but not impede reproduction. Our objective was to assess reproductive performance of heifers revaccinated with modified‐live viral vaccine prior to synchronized natural breeding. Sixty beef heifers were randomly assigned to four treatments. Groups A and B (n = 20/group) were vaccinated with Express FP at 2 days after initial detected estrus, and then revaccinated 32 days later, which corresponded to 10 days (Group A) or 31 days (Group B) before synchronized natural breeding. Groups C and D (n = 10/group) served as controls and were vaccinated with Citadel VL5 at the same time points as Groups A and B, respectively. Estrous behavior was assessed using radio frequency technology. Estrus synchronization was performed, with initiation occurring at revaccination (Groups A and C) or 21 days after revaccination (Groups B and D). After synchronization, heifers were submitted to a bull breeding pasture for 45 days. At the end of breeding period, heifers were ultrasounded to assess pregnancy. Progesterone concentrations were evaluated at unsynchronized and synchronized estrus and 10 days later, at initial pregnancy check, and at study end. Vaccination with Express FP 5‐VL5 did not result in significant negative reproductive impact based upon duration of interestral intervals, proportion of heifers exhibiting estrus within 5 days after synchronization, serum progesterone concentrations, pregnancy rates, and pregnancies in first five days of breeding season. Use of Express FP 5‐VL5 did not impede reproduction when revaccination was performed at 10 or 31 days prior to synchronized natural breeding.

EVALUATION OF GLUCOSE RESPONSE TO THREE INSULIN TYPES AND A CONTINUOUS GLUCOSE MONITORING SYSTEM IN HEALTHY AND SICK ALPACAS {#jvim12375-sec-0172}
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The purpose of the study was to evaluate the effects of different insulin formulations on glucose concentrations and evaluate the use of a continuous glucose monitoring (CGM) system in alpacas.

Six healthy alpacas and one hospitalized alpaca were utilized in this study. Intravenous catheters and the CGM system were placed in each healthy alpaca. Regular insulin (0.2 U/kg, IV and SC), NPH insulin (0.4 U/kg SC), insulin glargine (0.4 U/kg SC), and dextrose (300 mg/kg, IV) were administered to the healthy alpacas over a 2 week period. Following drug administration, blood samples were collected for glucose testing at set time points and the CGM recorded glucose concentrations every 5 minutes. The hospitalized alpaca also had the CGM system installed and blood samples were collected to measure glucose concentrations periodically. Data were compared using method comparison techniques, error grid plots, and ANOVA.

Blood glucose values in healthy alpacas decreased most rapidly following regular insulin administration as compared to the other formulations while the NPH insulin produced the longest glucose suppression effect. There was a lag in glucose concentrations obtained from the CGM compared to whole blood. The alpacas had no adverse reactions to the different insulin formulations. Due to the prolonged duration of effect of the NPH insulin it may be more appropriate for long term use in hyperglycemic alpacas. The CGM could be useful in monitoring glucose trends and reducing blood collection events; however it should not be the sole method for determining treatment protocols.

DETECTING EARLY BEHAVIORAL MARKERS OF RESPIRATORY DISEASE DEVELOPMENT IN YOUNG DAIRY CALVES {#jvim12375-sec-0174}
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Dairy calf pneumonia (DCP) is a prevalent, economically important condition affecting calves during the pre‐weaning and/or post‐weaning periods. The impact of DCP extends beyond the actual disease episode, having a negative effect on subsequent productivity and survivability of replacement stock. The ability to identify calves during the initial stages of respiratory disease development is difficult but objective monitoring of activity and feeding behavior may allow for earlier disease detection and intervention, potentially decreasing the consequences of DCP later on in the calf\'s life. The objective of this study was to identify early behavioral changes during respiratory disease development in young dairy calves subjected to different milk feeding levels (standard or high) and housing (individual or group).

Holstein calves from 3 different commercial dairy farms (standard milk/individual housing, high milk/individual housing, and standard milk/group housing) were used in this study. Overall respiratory disease incidence was approximately 20%. Social interaction/activity levels as well as feeding behavior were measured by fitting calves with collars containing sensors during the pre‐weaning period. Calves were screened daily for clinical signs of disease. Deep pharyngeal swabs were obtained from sick calves for detecting pathogens associated with respiratory disease by PCR and serum samples were collected for serology.

The automated sensor system successfully recorded activity levels of calves on the different farms. Total activity levels were correlated with milk consumption showing significant increases during the time preceding the feedings. In addition, a unique time series signature that corresponds with normal specific behaviors such as sleeping, standing, walking and/or bottle feeding was established from the acceleration data (activity levels). We used these data to identify any deviations from the norm. Calves with respiratory disease had increased activity levels when compared to healthy cohorts. In conclusion, these results suggest that calf behavior may be a useful means of disease detection.

RESPONSE OF BOVINE BRONCHIAL EPITHELIAL CELLS TO CO‐INFECTION WITH BOVINE RESPIRATORY SYNCYTIAL VIRUS AND MYCOPLASMA BOVIS {#jvim12375-sec-0176}
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Bovine respiratory disease (BRD) is the leading cause of bovine morbidity and mortality. Polymicrobial infection by viral and bacterial pathogens is common in BRD, leading to more severe disease than induced by single agent infection. These agents first encounter the host at the airway epithelial cell. In other species airway epithelial cells influence host immunity through release of cytokines and immune cell activation, but the role of bovine bronchial epithelial cell (BBEC) responses in BRD, and the influence of polymicrobial infection on BBEC, are poorly characterized. The objective of this study was to determine whether expression of cytokines and surface activation markers was altered in BBEC co‐infected with bovine respiratory syncytial virus (BRSV) and *Mycoplasma bovis* (Mb), as compared to responses of BBEC infected with either agent alone. BBEC isolated from cattle by bronchial brushing were grown and differentiated in air‐liquid interface culture. Cells were exposed to media (mock infection), 10^6^ pfu BRSV, 10^8^ cfu Mb, or both agents together, for 2, 4, or 24 hours. Infection was confirmed by immunofluorescence microscopy. Transepithelial resistance (TER) was measured before and after infection, and expression of mRNA for the cytokines interleukin 8 (IL‐8) and RANTES and the adhesion molecule ICAM‐1 was quantified by real time RT‐PCR. Transepithelial resistance was decreased in all cultures at 2 hours; TER increased toward baseline in mock and BRSV cultures but not in Mb or Mb + BRSV cultures. Expression of RANTES and ICAM‐1 was increased sharply at 2 hours after BRSV infection; this was suppressed by Mb. Expression of IL‐8 was increased by BRSV and Mb, but was increased more by coinfection. Disease in cattle infected with BRSV + Mb may be exacerbated by impaired migration of leukocytes or excessive neutrophil influx due to alterations in expression of RANTES, ICAM‐1, and IL‐8.

PREVALENCE OF BACTEREMIA IN DAIRY CATTLE WITH ACUTE PUERPERAL METRITIS {#jvim12375-sec-0178}
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The objective of this study was to determine the prevalence of bacteremia in dairy cattle with acute puerperal metritis (APM) and determine clinicopathologic factors associated with bacteremia in this population of animals.

Cows were examined at the time of identification of APM. A complete blood count, serum biochemical analysis and bacteriologic culturing of blood and lochial fluid were performed on each animal at the time of diagnosis. The same samples were collected from healthy herdmates of a similar parity and days in milk. Blood culture results and clinicopathologic parameters were compared between groups. Conditional logistic regression was used to evaluate factors associated with APM, while multivariate logistic regression was used to evaluate factors associated with bacteremia.

Bacteremia occurred in 53.1% (9/17) of cattle with APM and 53.3% (8/15) controls. *Bacillus* spp. was the organism most commonly isolated from the bloodstream in cattle of both groups. Bacteremic cattle in both groups were significantly less likely to have basophils in the peripheral circulation and more likely to have higher serum globulin concentrations.

Bacteremia is a common occurrence in post‐partum dairy cattle. It is likely that bacterial colonization of the involuting uterus, peri‐parturient immunosuppression, and systemic inflammation play a role in the high frequency of bacteremia. Further study is warranted to investigate the modes by which bacteria colonize the bloodstream in this population of animals and the significance of bacteremia on health and productivity of affected animals.

COMPUTED TOMOGRAPHY OF TYMPANIC BULLAE IN PRE‐WEANED DAIRY CALVES DIAGNOSED WITH OTITIS MEDIA {#jvim12375-sec-0180}
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Despite short and long term costs of respiratory disease and otitis media in pre‐weaned dairy replacement heifer calves, veterinarians and producers still lack the ability for effective early identification and prognostication of infected calves. The objective of this study was to use advanced imaging to improve established diagnostic techniques for calves diagnosed with otitis media.

Thirty Jersey calves were enrolled in three groups (n = 10 per group) from a single farm where respiratory disease is diagnosed by farm personnel using the McGuirk Respiratory Scoring System. Calves were grouped by (1) primary disease, (2) primary treatment failure and (3) multiple treatment failure. All calves were transported to the Veterinary Medical Teaching Hospital at Oregon State University for radiographs of the thorax and skull (focusing on tympanic bullae, 35° oblique from midline) and contrast enhanced computed tomography (CT). Following imaging, calves were euthanized and submitted for diagnostic pathology. For all calves, radiographs were compared to CT images to assess lesions of the tympanic bullae using gross pathology as the gold standard. Fluid in the bullae and osteolysis were measured using a scoring system and bullae wall thickness was directly measured for comparison.

No difference was found between radiographs and CT to detect fluid in the bullae. Radiographs were better able to quantify osteolytic lesions compared to CT. CT was better able to detect bony proliferation of the bullae wall compared to radiographs. Lateral wall thickness significantly increased with treatment failure compared to ventral and medial bullae walls with thicknesses of 0.13, 0.18, 0.21 cm for groups 1‐3, respectively (p \< 0.05). *Mycoplasma bovis* was cultured from 8 of 10 calves in each group. Of positive calves, all nasal swabs were positive. However, in lower airway *M. bovis* cultures, 25% from groups 1 and 2 and 12.5% from group 3 were negative.

These findings suggest radiographic imaging of tympanic bullae in dairy calves with otitis media is sufficient to detect fluid in the bullae and is better than CT to quantify osteolysis. This is relevant for clinical management of otitis media where CT is not available. We also show that nasopharyngeal swabs are appropriate for *M. bovis* detection in calves with clinical signs of otitis media.
